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The objective of this research was to determine metabolic adaptations and substrate 
utilization during chicken embryo development and to determine the influence of breeder age 
and egg size on embryonic growth and metabolism during development (embryonic day 11 to 
posthatch day 1). In Study One, for both small (n = 60, 53.2 ± 1.04 g) and large (n = 60, 69.0 ± 
1.86 g) eggs from 26 versus 42 wk-old broiler breeders, glucose content in albumen decreased to 
negligible levels by embryonic day (e) 11 whereas mannose and fucose remained constant. 
Higher yolk glucose content was observed in small eggs from e17 onwards whereas proportions 
of yolk linoleic and linolenic acids were greater in larger eggs. Liver adenosine monophosphate 
protein kinase (AMPK), the central cellular energy-sensor, was higher in activity in embryos 
from large eggs, and AMPK activity was at its highest for both sizes of eggs on e14. These 
observations suggest that glucose was consumed in early development (before e11). Lower liver 
AMPK activity and higher yolk glucose at later stages in small eggs from young hens suggests 
that anaplerotic metabolism is enhanced to alleviate the relative nutrient deficiency. 
In Study Two, a gas chromatography-mass spectrometry-based metabolomic profiling 
approach was employed to investigate effects of hen age and egg size on embryo metabolism. 
Principal component analysis of liver and blood metabolites showed separate clusters on both 
e14 and e20 from 32 and 51 wk-old hens. The separate clusters featured branched-chain amino 
acid, glycine, serine and threonine metabolism. Clear separation of metabolites was not observed 
for embryos from small versus large eggs at any developmental age. Breeder age had a larger 
influence on embryo metabolism and growth. Three clusters corresponding to liver metabolites 
from e14, e17 and e20 embryos formed a sub-tree that merged with the cluster from posthatch 
day 1 chicks in the Hierarchical clustering analysis. This result confirmed that embryo 
metabolism adapted during later development. Embryos from 51 wk-old hens displayed 
predominant developmental changes in ketone, glycerolipid and glutathione metabolic pathways 
in the liver compared to 32 wk-old hens. 
Study Three aimed to quantify gluconeogenesis, and substrate utilization and partition in 





C] glycerol into the chorio-allantoic fluid. Gluconeogenesis was higher in e19 
compared to e14 embryos, consistent with the need for increased liver and muscle glycogen by 
e19 embryos in preparation for emergence. The contribution of glucose to non-essential amino 
acid (NEAA) synthesis was greater in e14 vs e19 embryos, indicating a higher demand for amino 
acids for tissue growth. Glycerol contributed very little (< 5%) to gluconeogenesis; thus the 
remainder must be ascribed to amino acids. Relatively more of acetyl-CoA flux was derived 
from fatty acid metabolism in e14 embryos compared to 3-carbon pool substrates. 
In summary, this thesis research established aspects of embryo metabolism and nutrient 
partition in developing embryos that previously were unknown. This included demonstration of a 
role of AMPK in development, the influence of breeder age on global embryo metabolism, and 
metabolic adaptations in gluconeogenesis, Krebs cycle activity and glycerol metabolism during 
the latter half of chicken embryo development. 
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CHAPTER 1: INTRODUCTION 
 
The rate of embryonic growth and development is largely influenced by the initial egg 
size, composition of egg nutrients (yolk, albumen) and the period of incubation (Ricklefs, 1987; 
Wilson, 1991). Production records and field observations indicate a high mortality rate of 
embryos from small eggs (< 55 g), especially those from younger layers (< 30 wk). Initial egg 
size and nutrient composition determine substrate availability, and therefore necessitate 
alterations in substrate utilization and metabolic pathways during embryo development. This 
doctoral dissertation investigated the metabolic adaptation and substrate utilization during 
chicken embryo development, and determined the influence of breeder age and egg size on 
embryo growth and metabolism during later embryo development, i.e. from embryonic day (e) 
11 of incubation to posthatch day 1. 
It is well documented that egg size increases with breeder age, and chicks hatched from 
larger (65-70 g) eggs are heavier and have a larger residual yolk sac (Weatherup and Foster, 
1980; Wilson, 1991; Lourens, et al., 2006). In addition, the ratio of yolk to albumen in large (62-
67 g) eggs is greater than in smaller (52 g) eggs (Peebles et al., 2000). Studies have shown that 
embryos and broiler chicks from small (< 55 g) compared to large (65-70 g) eggs are associated 
with high mortality, poor uniformity and reduced growth performance (Noble et al., 1996; 
Peebles and Brake, 1987). As the nutrient environment is established once the egg is formed, the 
ability of the embryo to regulate patterns of substrate utilization is critical for development and 
emergence. Latour et al., (1996) observed lower blood glucose and tissue glycogen levels in 
embryos from small compared to large eggs. Moreover, the transfer of yolk lipids into the 
embryo towards the end of the incubation period was reduced in eggs from young compared to 
2 
 
old hens (Noble et al., 1986; Yafei and Noble, 1990). These phenomena of energy regulation 
might be linked to higher embryo mortality, reduced posthatch body weight and suboptimal 
growth performance in the small eggs from younger breeders.  
Metabolic adaptation, especially energy partitioning, in the chicken embryo is most 
pronounced during later development.  The yolk sac contains 45% lipids; thus lipid metabolism 
dominates in embryos from mid incubation until 2-3 days before hatch (Sato et al., 2006; Moran, 
2007). Gluconeogenesis and glycogenesis are vital for embryo survival and early posthatch life 
to ensure an optimal supply of glucose. The Krebs cycle generates ATP and its metabolites are 
extensively linked to intermediary metabolism. The pentose phosphate pathway ensures the 
indispensible supply of ribose for nucleic acid synthesis, because there are very minimal amounts 
of nucleic acids in a freshly laid egg (Reddy et al., 1952; De Oliveira et al., 2008).  However, 
little is known about how metabolic pathways change during later development, and the 
importance of various substrates utilized for energy metabolism. Moreover, sensing and 
regulating energy status is of particular importance in developing chicken embryos, given that 
the supply of energy substrates in the egg is fixed. In the past decade, 5’-adenosine 
monophosphate-activated protein kinase (AMPK) has been demonstrated to be a key metabolic 
regulator for sensing energy status changes in multiple animal and cellular systems (Kahn et al., 
2005; Towler and Hardie, 2007; Lage et al., 2008). And, despite recent work characterizing the 
tissue distribution of AMPK and its subunits in the developing chicken embryo (Proszkowiec-
Weglarz and Richards, 2009), the role of the AMPK sensing system in the developing chicken 
embryo is unknown. 




The aim of this research was to characterize substrate utilization during metabolic 
adaptation of chicken embryos as well as the role of energy regulation mechanisms (i.e., AMPK) 
from the latter period of development to posthatch day 1.The main factors investigated were 
breeder age (old vs young) and egg size (small vs large). These factors determine egg nutrient 
composition (e.g., yolk, albumen, fatty acids and carbohydrates) which influences substrate 
utilization in developing chicken embryos. 
Research Hypothesis 
 
It was hypothesized that egg size and hen age would influence embryo development by 
necessitating changes in metabolic pathways that lead to differential use of energy substrates. 
Moreover, the regulation of key metabolic events also was expected to change during 
development, and as a consequence of egg component composition. 
Thus, the differences in egg size will dictate the absolute amount of egg nutrients 
available. Further, because hen age has a large influence on the yolk to albumen ratio, we also 
expected that embryonic metabolism and partitioning will differ in response to the different 
nutrient environments.  
Although many studies have been conducted to evaluate the effect of egg size on embryo 
growth and hatchability, there is a lack of quantitative information on metabolic changes 
resulting from the difference in egg size or hen age per se. Also, it is unclear as to the 
mechanisms that dictate the patterns and extents of utilization of substrates by the developing 




In the past fifteen years, a new field of metabolomics has come to the forefront of 
metabolic exploration. The beauty of metabolomics lies in the fact that, unlike genomics or 
proteomics, it is a direct reflection of the phenotype or the physiological state of a biological 
system (e.g. whole animal, organ or cell). The technique can be used to capture a ‘metabolic 
snapshot’ of the active metabolic events. In recent years, animal scientists have started to employ 
this approach to determine the specific metabolites and metabolic pathways for suboptimal 
growth and development in piglets (Lin et al., 2012; Getty et al., 2013). 





C] glycerol) injection approach to investigate changes in the flux of 
substrates towards major metabolic pathways such as gluconeogenesis and the Krebs cycle in 
developing chicken embryos (Sunny and Bequette, 2010; 2011). This approach employs 
13
C-
mass isotopomer distribution analysis (MIDA) of metabolic intermediates and end products of 
pathways to calculate the fluxes and partitioning of substrates (e.g., glucose and glycerol) 
through central metabolic pathways. Thus, MIDA establishes the enzyme pathways involved in 
substrate use and the relative activity of enzymes and associated pathways. In the current 
research project, we employed both metabolic profiling and stable isotope tracer approaches to 
investigate the influence of egg size and hen age on metabolic development of the embryo, and 
to quantify the changes in metabolic pathways in response to varying nutrient compositions. 
Experiment Objectives 
 
1. Establish the patterns of nutrient utilization and metabolism in developing chicken 
embryos (e11 to posthatch day 1) hatched from small vs large eggs (Study One). We 
hypothesized that the different nutrient environments of small and large eggs would 
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necessitate an in ovo energy-sensing mechanism(s) to coordinate embryo growth, and that 
AMPK mediates these alterations. Further, this study aimed to quantify the available 
substrates (carbohydrates and fatty acids) in albumen and residual yolk from the two 
sizes of eggs (Chapter 3).  
2. Determine the influence of egg size and breeder age on metabolic events during the late 
periods of development (e14 to posthatch day 1) employing metabolomics (Study Two).  
This study aimed to test the hypothesis that the activity of metabolic pathways involved 
in macronutrient metabolism differs during development of chicken embryos and in 
posthatch chicks due to the varying nutrient environments of eggs of different sizes and 
those from different ages of hens (Chapter 4). 
3. Develop a constant infusion tracer ([U-13C] glucose and [U-13C] glycerol) approach to 
establish the rates of gluconeogenesis and substrate utilization in e14 and e19 embryos 
(Study Three). It was hypothesized that glucose and non-essential amino acid synthesis 
(NEAA) would increase from e14 to e19 in embryos due to the greater needs for glucose 
for muscle and liver glycogen accumulation and NEAA for net tissue protein gain. The 
study aimed to attain a high level of incorporation of 
13
C into metabolites of intermediary 









CHAPTER 2: LITERATURE REVIEW 
 
The Significance of Egg Hatchability to the Industry 
 
 In the US, per capita consumption of poultry meat (96 lb) is nearly equal to that of beef and 
pork combined (104 lb) in recent years (USDA, 2013) because of the public’s perception of 
chicken and turkey meat as being low in fat, wholesome and nutritious. Poultry production will 
need to continue to rise to keep up with this increasing demand (USDA, 2007). In response to 
higher feed costs and to meet the large meat demand, the poultry industry will have to increase 
production efficiency by improving nutritional efficiency and reducing productive losses. Although 
growth rate and meat yield of commercial poultry have improved linearly over the last few decades 
(Havenstein et al., 2003a, b; Havenstein et al., 2007), embryonic death and ~80% hatchability 
continue to represent the largest losses in potential productivity, costing the US broiler and turkey 
industries $500 M per annum (Schaal and Cherian, 2007). Another issue facing the poultry industry 
is that chicks hatched from small eggs experience poorer hatchability and suboptimal posthatch 
growth performance compared to those from typical and larger sized eggs (Peebles and Brake, 
1987). It is estimated that reducing early chick mortality by 0.25% will save the broiler industry 
over $ 5M per annum (Peebles, 2007).  
  Currently in the poultry industry, meat birds reach market weight in ~6 weeks.  
Therefore, the period encompassing the 21-day incubation period plus 10 days post-hatch 
represents ~50% of the broiler’s lifespan. Any factors that promote or delay growth and 
development during this neonatal period will have a marked effect on overall growth 
performance and health of chicks. Thus, this dissertation research will focus on the period 
between embryonic (e) day 11 and posthatch day 1 of broiler chick embryo development, a 
critical window during which the embryo undergoes rapid growth and development, as the chick 
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prepares for emergence and life outside the egg. This period is also important to chicken survival 
during the first 1-3 days posthatch when stored glycogen and residual yolk components aid in 
the transition to feed grains (Lilburn, 1998; Vieira and Moran, 1999).  
From Egg to Chick 
 
Once the ovum is fertilized in the infundibulum, germ development is initiated. Fertilized 
germinal disc development occurs during the first 24 h (42 
◦
C) while egg formation is being 
completed. Germ development temporarily ceases when the egg is laid and the environment 
temperature drops below 27 
◦
C (Romanoff, 1939).  When incubation begins, germ development 
resumes. A visible vascular system aids the germ in the absorption of nutrients from the 
surrounding yolk (Litke and Low, 1975) and albumen (Deeming, 1989). Oxygen access is 
limited to simple diffusion at this point (Baumann and Meuer, 1992); therefore the energy supply 
is dependent on glycolysis of glucose to lactic acid until the chorioallantoic compartment is 
formed (Kucera et al., 1984, Moran, 2007).  
Rapid vascular system development enables the exchange of O2 and CO2 with shell pores 
(Tullety and Board, 1976), and fatty acid β-oxidation becomes the primary energy source for 
embryo development. Around e 8, with chorioallantoic respiration established, the vascular 
system is fully developed to ensure O2-CO2 exchange (Levinsohn et al., 1984). The embryo is 
structurally completed by e14 (Moran, 2007), and oxygen consumption reaches a plateau 
(Christensen et al., 1996). A simplified display of embryo development is shown in Figure2.1. 
Embryo death occurring at this stage is mainly due to nutritional deficiency of the breeder 




















During the last week of embryo development, albumen enters the amniotic sac, and the 
amnion is orally consumed by the embryo.  The albumen-amniotic mixture enters the yolk sac 
through the stalk to allow partial absorption of protein by enterocytes (Moran, 2007). 
Gluconeogenesis increases to ensure an adequate supply of glucose for glycogen accumulation in 
the liver and muscles. 
Emergence is initiated when internal pipping occurs around e 20. Oxygen supply 
becomes limited, and energy support is mainly from glucose metabolism provided by the 
glycogen reserves. The metabolism of glucose to lactic acid reduces at this point once pulmonary 
respiration is initiated (Garcia et al., 1986; Hoiby et al., 1987). The remaining yolk sac is 
internalized and conserved for the transition during the first two days posthatch. Upon hatch, the 
liver and intestines continue to develop to prepare for the transition to feed consumption and 
digestion. During this latter period, dramatic changes in physiology and metabolism occur to 
ensure transition of the hatchling. Any interference during this transition period may 
significantly affect embryo survival, or result in suboptimal growth performance after hatch.  
To summarize, embryo development can be divided into three phases. The first week of 
features the establishment of germ and chorioallantoic compartment formation. The second week 
is characterized by embryo completion and O2-CO2 exchange of chorioallantoic respiration. And, 
the last phase includes accumulation of glycogen in the liver and muscle tissues, beginning of 
pulmonary respiration, internalization of the remaining yolk sac, shell pipping and emergence. 












 Figure 2.2 Chicken embryo development periods and major physiological and metabolic events,   











Factors Affecting Chicken Embryo Development 
 
A variety of factors can affect chicken embryo development, such as the environment 
(temperature, humidity), seasonal variations, breeder genetics, nutritional status, and maternal 
age to name a few. These factors may directly contribute to hatchability and posthatch survival. 
Within a species, the breeder may lay eggs with enormous differences in size. The size 
difference can also occur within the same clutch (Surez et al., 1997; Mortola and Awam, 2010). 
If the embryonic growth trajectory is genetically conserved, then the weight difference of 
posthatch chicks and future growth performance of the hatchlings must be attributed to the egg 
nutrient supply. 
Egg Size (weight) 
It is well known that eggs of different sizes produce different size hatchlings (Mortola 
and Awam, 2010). Egg size differs due to several reasons, e.g. breeder age, nutritional status and 
laying time during a clutch. A strong positive correlation exists between egg weight at set and 
embryo weight on e 14, e 16, and e18 (Shanawany, 1984; Sunny and Bequette, 2010). Studies 
have shown that larger eggs have a greater surface area for O2 diffusion. Because the availability 
of O2 towards the end of embryo development is critical to energy metabolism, this may be more 
pronounced in the embryos of small eggs with smaller surface areas (Burton and Tullett, 1985; 
Tazawa et al., 1992).  Hatchlings produced from large eggs also have a greater yolk residue 
(Williams, 1994; Lourens et al., 2006), which provides more nutrients for embryos during the 
transition period and results in heavier body weight at hatch (Mortola and Awam, 2010; Sunny 
and Bequette, 2010; Ulmer-Franco et al., 2010). Further, hatchling weight is positively correlated 
with blood glucose concentrations at hatch (Christensen et al., 2000). Lower blood glucose 
concentration is associated with lower hatchability in small eggs (Christensen et al., 2000).  Not 
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surprisingly, hatchlings from small eggs also have relatively smaller breast muscle, liver and 
adipose tissue, which indicate less glycogen and fat storage for emergence. 
Breeder Age 
Breeder age is one of the most important factors that influence the yolk to albumen ratio 
in an egg (O’Sullivan et al., 1991). It is known that egg weight and the proportion of yolk both 
increase with increasing hen age (Suarez et al., 1997); however, egg shell thickness decreases 
with increasing hen age (Peebles et al., 2000). Shell thickness and pore number influence gas 
exchange and moisture loss during the incubation period (Wangensteen et al., 1970-1971; Reis et 
al., 1997; Peebles et al., 2001). While yolk provides more than 90% of the energy requirement of 
the developing embryo (Romanoff, 1960), a smaller proportion of yolk relative to albumen is 
disadvantageous to embryos from small eggs (Ulmer-Franco et al., 2010). The posthatch body 
weight differences and higher mortality rate were linked to small eggs derived from young hens 
may also lead to less development of physiological systems (McNaughton et al., 1978). Eggs 
from older hens hatch earlier than those from younger hens (Lowe and Garwood, 1977), 
probably because of efficient nutrient deposition into the eggs leading to optimal use during 
embryonic growth (Shanawany, 1984). 
Relationship between Breeder Age and Egg size 
In general, egg size increases with hen age; however, during a given laying cycle 
(clutch), breeders produce eggs of variable sizes. Therefore, egg size differences can be 
attributed to hen age or laying time during the clutch. Small eggs from young hens (32 wk) have 
a lower yolk to albumen ratio as compared to large eggs from older hens (41 wk) (Joseph and 
Moran, 2005). Surprisingly, small eggs laid at beginning and end of the clutch have a greater 
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proportion of yolk than large eggs from the same clutch (Vieira and Moran, 1998). Shanawany 
(1984) showed that e18 embryo weight increased with increasing breeder age, regardless of the 
initial egg weight.  
 
Important Metabolic Pathways during Development 
 
Metabolic pathways of greatest importance to the embryo are related to energy 
metabolism, and are dependent on the availability of O2. Current information on regulation of 
metabolic pathways to support embryonic development is limited. The following sections 
elucidate the importance of various metabolic pathways during different stages of embryo 
development. Figure 2.3 summarizes the central metabolic network. 
Glycolysis and Krebs cycle 
Glycolysis plays a particularly important role during early embryonic development when 
the chorioallantoic compartment is not completely formed. Through glycolysis, 1 mole of 
accessible glucose produces 2 mol of ATP and 2 units of pyruvate. When O2 supply is limited, 
pyruvate is converted to lactate in order to maintain glycolysis self-functioning.  Although 
carbohydrates are only 3% (DM basis) of egg content at set (Romanoff and Romanoff, 1967), 
this limited supply ensures the successful transition from anaerobic to aerobic metabolism. As 
the vascular system develops, pyruvate from glycolysis enters the Krebs cycle for further and 
complete oxidation rather than formation of lactate. 
The Krebs cycle receives inputs into the acetyl-CoA pool from fatty acid β-oxidation to 
generate most of the energy required for embryo development. The Krebs cycle also provides 
intermediates for gluconeogenesis and non-essential amino acid (NEAA) synthesis, and reducing 
equivalents (including NADH and FADH2) are formed to generate ATP via the electron 
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transport chain (Moran, 2007). Because the initial egg supply of glucose is finite, the glycolytic 
pathway is truncated at pyruvate at the beginning and end of embryo development when O2 
availability is marginal (Freeman, 1969; Tazawa et al., 1983).  
Lipid Metabolism 
The egg contains ~31% yolk (DM basis), which is comprised primarily of lipids (33%) 
(Burley and Vadehra, 1989; Deeming and Ferguson, 1991). Yolk lipids are the major source of 
energy and are important building blocks for tissue and brain development (Speake et al., 1998; 
Sato et al., 2006). Triglycerides and phosphoglycerides are the main forms in yolk lipids (92%) 
and are preferentially utilized to generate energy (Burley and Vadehra, 1989; Deeming and 
Ferguson, 1991).  Triglyceride hydrolysis yields free fatty acids and glycerol. After the formation 
of the chorioallantoic compartment, acetyl-CoA generated from fatty acids β-oxidation enters the 
Krebs cycle to yield ATP (Krebs, 1972). Previous work in our laboratory demonstrated that 
glycerol is a significant substrate for gluconeogenesis in the developing chicken embryo (Sunny 
and Bequette, 2011).  
Rapid cell proliferation in developing chicken embryos requires the formation of 
membrane phospholipid from yolk stores (Speake et al., 1998). Some n-3 and n-6 long chain 
polyunsaturated fatty acids are believed to be essential in the functional differentiation of certain 
organs and tissues. For example, docosahexaenoic acid (C22:6 n-3) is of importance in brain and 
retina development (Anderson et al., 1990; Cherian and Sim, 1992). The final week of 
embryogenesis features rapid transfer of lipid components in the form of lipoprotein particles 
from yolk to the embryonic circulation (Noble and Cocchi, 1990; Shand et al., 1993).  
High levels of lipoprotein lipase activity were observed in adipose tissues of embryos 
(Speake et al., 1992) whereas lipogenesis from carbohydrate precursors was not active 
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(Goodridge, 1974). However, subcutaneous fat was detected in embryos as early as e12, which 
suggests that the growth of adipose tissue is dependent on uptake of yolk lipids (Langlow and 
Lewis, 1972; Ferkas et al., 1996).  
Amino Acid Metabolism 
Both yolk and albumen contain significant, but a fixed, amount of protein (amino acids) 
for tissue growth and development. Free albumen enters via the amniotic sac, and thus albumen-
amniotic mixture is orally consumed by the embryo. The macronutrients in this mixture are 
absorbed by enterocytes in the duodenum and jejunum (Moran, 2007).  Albumen can also enter 
the yolk sac through the stalk with the aid from antiperistaltic activity of the colon (Sugimoto et 
al., 1989; Bryk and Gheri, 1990). The amino acid profile of egg proteins remains the same 
throughout development, and utilization of amino acids from the yolk and albumen occurs at a 
constant rate (Ohta et al., 1999). Except for glycine and proline, which are required in higher 
proportions for collagen synthesis, the rate of use of most amino acids occurs at a similar rate 
(Ohta et al., 1999).  
In addition to their essential role in tissue protein synthesis, amino acids also serve as 
important substrates for gluconeogenesis. Glutamine, glutamate, alanine, aspartate, serine and 
threonine are the major gluconeogenic amino acids, not only in avian species, but also in 
mammals (Heitmann et al., 1973; Lobley, 1992; Sunny and Bequette, 2010). Apart from tissue 
protein synthesis and gluconeogenesis, some amino acids, such as glycine and aspartate, are 
indispensible components of nucleotide bases. Glycine and glutamine also serve as important 
substrates for uric acid synthesis, the primary end product of amino acid catabolism in the 
embryo that is excreted into the allantois (Levenberg et al., 1956; Sonne et al., 1956).   
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Gluconeogenesis and Glycogenesis 
Although glucose is initially catabolized to support early embryo development, glucose 
concentration increases in the plasma from < 100 mg/dl in early developmental stage to levels 
reaching 150-160 mg/dl at the time of hatch (Hazelwood, 1986). This phenomenon suggests that 
gluconeogenesis from non-glucose substrates must increase in activity as the embryo develops. 
A study of isolated chicken liver cells showed that lactate, pyruvate, and dihydroxyacetone were 
the top three substrates that contribute to glucose synthesis (Brady et al., 1979). In contrast to 
mammals, gluconeogenesis from lactate appears to be greater than from pyruvate in avian 
species. A possible explanation for this species difference relates to the increased gene 
expression of the liver mitochondrial (m) isoform of phosphoenolpyruvate carboxykinase 
(PEPCK) that predominants from e 13 to adulthood, whereas gene expression of the liver 
PEPCK cytosolic (c) isoform decreases from e13 to negligible levels by e20 (Savon et al., 1993). 
Gluconeogenesis requires the transfer of carbon substrates (pyruvate, amino acids and Krebs 
cycle intermediates) from the mitochondria to cytosol and the generation of cytosolic NADH 
from the conversion of malate to oxaloacetate. When the PEPCK (m) isoform predominates 
during later embryonic development, pyruvate exits the mitochondria as phophoenolpyruvate, 
without transfer of NADH.  The oxidation of lactate to pyruvate generates one NADH in the 
cytosol.  Only one NADH is consumed per each triosephosphate dehydrogenase reaction in 
gluconeogenesis.  It is important to balance the cytosolic redox state by synthesizing 
phophoenolpyruvate in the mitochondria, as this obviates production of another NADH from the 
malate to oxaloacetate conversion in the cytosol (Yang et al., 2009). In addition to the three 
substrates mentioned above, glycerol has also been shown to be a significant substrate for 
gluconeogenesis, especially in embryos from small eggs (Sunny and Bequette, 2011). 
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Glucose arising from gluconeogenesis is predominantly stored in the liver and muscle as 
glycogen (Matthews and Holde, 1990; Christensen et al., 2001). Synthesis of glycogen is 
extremely critical for embryo survival, particularly during the last few days of development. 
Nevertheless, glycogenolysis is as important as glycogenesis, since glycogenolysis provides free 
glucose for energy. When the embryo approaches the plateau stage of O2 consumption during 
later development, the energy supply switches from fatty acid β-oxidation to glycolysis utilizing 
glucose mobilized from glycogen storages (Donaldson and Christensen, 1991). Both 
glycogenesis and glycogenolysis are tightly regulated by hormones to maintain homeostasis.  
Pentose Phosphate Pathway 
The pentose phosphate pathway is important for cell proliferation and tissue growth, as it 
provides ribose, a necessary component for synthesis of nucleotides. It is known that the initial 
supply of preformed nucleic acids in freshly laid eggs is limited (Reddy et al., 1952), thus the 
ability to de novo synthesize nucleic acids becomes vital during embryo development. However, 
purines, but not pyrimidines, are mostly synthesized (> 95%) de novo by hens (Berthold et al., 
1995), which suggests that the initial deposition of pyrimidines into the egg by the hen and the 
availability of precursors for purine biosynthesis by the embryo will greatly influence 
development. Furthermore, the pentose phosphate pathway generates reducing equivalents, 
NADPH and NADH, which enter the respiration chain to produce ATP and which are essential 
for reactions involving fatty acid and nucleic acid synthesis.  
 
Hormonal Control of Metabolic Pathways 
 
The endocrine system, including the pituitary, hypothalamus and pancreas, develops in 
chicken embryo during the first week of incubation. The hormones produced from these organs 
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determine metabolic patterns throughout development and influence the partition of nutrients and 
substrates during embryonic growth.  
Plasma glucose can be detected in the chicken embryo as early as e4, and is found to 
increase gradually during the entirety of development. On e4, glucagon secreted from pancreatic 
A cells begins to circulate freely or loosely bound to plasma albumin (Hazelwood, 1986). It has 
been reported that glucagon levels are two to five times higher in avian plasma compared to that 
in mammals (Weir et al., 1976). Glucagon regulates carbohydrate, lipid and amino acid 
metabolism by counteracting the effects of insulin (Jiang and Zhang, 2003). The major 
physiological effect of glucagon is to increase plasma glucose by enhancing hepatic 
gluconeogenesis and glycogenolysis. Glucagon is also the primary hormone in avian species that 
stimulates lipid mobilization from adipose tissue, resulting in elevated plasma free fatty acid 
levels (Leclercq, 1984). Therefore, plasma glucose may be spared when fatty acids are utilized, 
which is largely under control of glucagon or the glucagon/insulin ratio. Glucagon plays an 
important role not only during embryogenesis, but also in the transition of the embryo from a 
high-fat, low-carbohydrate supply in ovo to a high-carbohydrate, low-fat diet after hatch 
(Langslow et al., 1979).  
Insulin has been shown to accelerate chick embryonic growth and morphological 
development (De Pablo et al., 1990). The reversed effects of insulin, compared to glucagon, are 
to reduce glycogenolysis and simultaneously promote glycogenesis. The main target tissues, 
which are essentially the same as those in response to glucagon, include liver, muscle and 
adipose tissue (Dickson and Langslow, 1978; Hazelwood, 1986). In vitro and in vivo studies 
have shown that insulin appears to be more active in the liver of chickens than that in mammals. 
Possible explanations are greater affinity of chicken insulin for liver binding sites and a slower 
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dissociation rate of the insulin-receptor complex that further potentiates the role of insulin in 
metabolic regulation (Simon et al., 1974). The molar ratio of insulin to glucagon increases 
between embryonic e 12 to e15 and decreases during pipping and hatch, thus supporting the high 
energy demands of hatching (Lu et al., 2007).  
Corticosterone is the primary glucocorticoid secreted by the avian adrenal cortex. In the 
chicken embryo, plasma glucocorticoid concentration reaches a peak around e 14-e16 (Wise and 
Frye, 1973) and immediately before hatch (Marie, 1981; Tanabe et al., 1986).  Effective 
glucocorticoids stimulate gluconeogenesis, thus resulting in greater hepatic glycogen deposition. 
Extrahepatic amino acids are mobilized for gluconeogenesis by the action of glucocorticoids 
(McKay and Cidlowski, 2003; Hall, 2010). Hayward and Wingfield (2004) reported that 
corticosterone implanted into the hen was transferred to the quail egg yolk and resulted in slower 
growth of the hatchlings.  
The catecholamines dopamine, norephinephrine and epinephrine are synthesized from 
tyrosine (Kubrusly et al., 2007), and at e9, catecholamines have been detected in embryo plasma, 
with levels increasing up until time of hatch (Hazelwood, 1986). Catecholamines enhance 
glycogenolysis and lipolysis which result in the elevation of blood glucose and free fatty acids 
(Connolly et al., 1991; Stevenson et al., 1991).  
Growth hormone is abundant in neural tissues of the chicken embryo during the first 
week of incubation and localized to specific tissues and cells during later development (Harvey 
et al, 2001). The population of growth hormone secreting cells is increased by corticosterone 
between e11 and e13. The main functions of growth hormone include promotion of lipolysis and 
glycerol release and increase of gluconeogenesis and protein synthesis. 
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The thyroid hormones, triiodothyronine (T3) and thyroxine (T4), participate in numerous 
physiological processes in both mammals and avians, especially regulating heat production 
during chicken embryo development (Cogburn et al., 1989; McNabb, 2000). Plasma T3 was 
detected on e9.5 and remained unchanged until pulmonary respiration starts (McNabb, 2000; 
Reyns et al., 2003; Lu et al., 2007). The elevated plasma T4 level occurs during the middle 
period of development, which is because of increased thyroid hormone receptors in the liver and 
brain (Bellabarba et al., 1988). Both T3 and T4 are positively correlated with chicken embryo 
body weight, suggesting that these hormones are critical in maintaining normal embryo growth 






























Energy Regulation during Embryo Development 
 
Embryonic metabolism undergoes dramatic changes, especially during emergence. 
Sensing and regulating energy status is of particular importance in embryonic development, 
given the fixed supply of energy substrates available to the embryo throughout development. 
Reports over last 15 years clearly demonstrate that AMPK is a key sensor and regulator of 
cellular and whole body energy homeostasis in nearly all cell types and in many species. To date, 
clear demonstration of the role of AMPK in chicken embryo metabolism remains limited. 
AMPK and Its Activation 
AMP-activated protein kinase is a sensor and regulator of energy balance at both single-
cell and whole-body levels (Kahn, 2005). The native form of AMPK is a hetero-trimer 
comprised of catalytic α subunits and regulatory β and γ subunits (Xiao et al., 2007, McBride et 
al., 2009). The α subunit includes two isoforms, α-1 and α-2, encoded by distinct genes in 
mammals. These subunits have conventional Ser/Thr kinase domains, with the conserved 
threonine residue which becomes phosphorylated in the activation loop once it is activated 
(Hawley, et al., 1996). The β subunit is regarded as a protein scaffold with glycogen-binding 
domains. The γ subunit contains four repeats of a structural motif which is referred to as 
cystathionine β-synthase. These motifs act in pairs to form two domains and are termed Bateman 
domains. Each Bateman domain preferentially binds to one molecule of AMP at five- fold higher 
affinity comparing to the binding of ATP molecules (Hardie, 2007a). 
Similar to mammals, chicken AMPK is also composed of one catalytic and two 
regulatory subunits. Proszkowiec-Weglarz et al. (2006 a, b) identified two alpha, two beta and 
three gamma subunit isoforms in broiler chickens. However, studies have also shown that 
23 
 
expression of the α -1subunit is highest in the liver whereas the α-2 subunit is preferentially 
expressed in breast muscle (Proszkowiec-Weglarz and Richards, 2009). 
AMPK is well known as a sensor of energy status in mammals as well as in broiler 
chickens (Hardie, 2007a; Proszkowiec-Weglarz et al., 2009). Activation of AMPK is brought 
about by metabolic stress signals, leading to production of ATP (Kahn et al., 2005). Once 
activated, a cascade of reactions turns on catabolic pathways to generate ATP, while the ATP-
consuming processes are turned off (Hardie, 2007b). AMPK is activated through the binding of 
AMP by three different mechanisms: 1) AMP allosterically activates the AMPK complex, 2) 
AMP promotes activation of the AMPK complex by stimulating phosphorylation of Thr-172 
residue in the activation loop by an upstream kinase, and 3) AMP inhibits dephosphorylation of 
Thr-172 by protein phosphatases. All three mechanisms ensure that the AMPK system is 
sensitive to small changes in the cellular AMP/ATP ratio (Kahn et al., 2005). AMPK monitors 
the cellular energy status not only through the AMP/ATP ratio, but also by glycogen (McBride et 
al., 2009).  Activated AMPK inhibits the anabolic pathways which require ATP, e.g. liver 
gluconeogenesis is reduced by decreasing gene expression of PEPCK (c) and glucose-6-
phosphatase (Lochhead et al., 2000). 
Metabolic Investigation Approaches 
 
The central pathways involving carbohydrates, lipids, and amino acids are largely 
interlinked. Carbon skeletons of substrates and intermediates are highly exchanged among 
several pathways. Intermediary fluxes through the entire metabolic network determine the 
partition and utilization of substrates. It may be misleading if we consider one pathway 
separately from others, because changes in one reaction can readily alter the subsequent 
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pathways which seem to be remotely connected (Reeds et al., 1997). Although various metabolic 
pathways intersect freely at the whole body level, specific pathways may be compartmentalized 
between tissues and within cells. Thus, metabolic pathway investigation must be performed at 
the whole tissue or animal level. However, most of the current understanding of nutrient 
metabolism has been derived from in vitro studies (Bequette et al., 2006). As a result, there is a 
need to focus on in vivo models to better understand the underlying mechanisms of metabolic 
regulation. 
The technological advances in mass spectrometry (MS) have been increasingly applied to 
study dynamic metabolic processes and their integration at the whole body level (Owen et al., 
2000). The review below includes two popular approaches currently being employed in the 
studies of metabolic pathways.  
Metabolomics  
Metabolomics refers to the study of the entire set of small molecules (< 1500 Da) in a 
biological sample (Wishart, 2007). As such, the metabolome is defined as a collection of small 
molecules produced by cells. It allows for investigating the relationship between mechanistic 
biochemistry and particular phenotypes (Patti et al., 2012). Metabolites are different from genes 
and proteins, the functions of which are influenced by epigenetic regulation and post-
translational modifications. They provide the instantaneous information about the biochemical 
reactions ongoing in the organism and therefore are unequivocally correlated with the particular 
genotype. Metabolomics approaches allow for the analysis of hundreds of metabolites in a given 
biological sample to provide a snapshot of multiple metabolic pathways simultaneously (Scalbert 
et al., 2009). System-wide changes of metabolic pathways in response to specific phenotypic 
perturbations have been identified when applying metabolomics profiling approaches and 
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bioinformatic tools (Patti et al., 2012). Currently, nuclear magnetic resonance (NMR) 
spectroscopy and other diverse chromatographic platforms, such as gas chromatography (GC), 
liquid chromatography (LC) and capillary electrophoresis (CE) coupled to MS are the major 
instruments for metabolomics studies. MS techniques are particularly advantageous because of 
their sensitivity, selectivity and ease of use, and have been used extensively in the metabolomics 
studies. There are two separate approaches to metabolomics that are described in detail below. 
Targeted Metabolomics 
Targeted metabolomics focuses on absolute quantification of selected metabolites, which 
may relate to one or more pathways of interest. It is usually used to interrogate a particular 
biochemical question or to test hypotheses that are typically related to certain pathways (Koal 
and Deigner, 2010; Patti et al., 2012), e.g. the targeted approach is effective when measuring the 
influence of a gene modification(s) on a specific enzyme(s). Researchers monitor changes in 
metabolic activity which could be attributed to differential production of a particular metabolite 
involved in the pathway. The workflow of targeted metabolomics includes metabolite extraction, 
selected reaction monitoring, instrument setting optimization and standard curve construct, and 
data analysis (Patti et al., 2012; Roberts et al., 2012) (Figure 2.4). 
Research on measuring targeted metabolites has long been in practice, dating back to 
1974 (Davison et al., 1974). The targeted approach undoubtedly played an important role in the 
development of the metabolomics field. Advanced instrumentation, such as NMR and MS, 
provides a highly sensitive and reliable method to measure a large number of metabolites with 
high throughput. In a human patient study of diabetes, a target metabolomics approach was used 
to measure the patient response to glucose challenge (Shaham et al., 2008). Using the LC-
MS/MS platform, the levels of three bile acids, i.e. glycocholic acid, glycochenodeoxycholic 
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acid and taurochenodeoxycholic acid, were found to be more than double within the first 30 min 
after glucose intake. The results were unexpected as those bile acids had never been correlated 
with glucose homeostasis.   
However, since this approach only measures specific metabolites of interest to the 
researcher, the metabolites which are not well documented or identified are overlooked. This 
shortcoming will result in incomplete characterization of metabolic networks and pathways, and 
likely lead to misinterpretation of metabolic events. To overcome some of these shortcomings, 
an untargeted metabolomics approach can be applied. 
Untargeted Metabolomics  
Untargeted metabolomics approaches aim to identify or profile as many metabolites as 
possible in a given biological sample without bias (Vinayavekhin and Saghatelian, 2010; Patti et 
al., 2012). It is more global in assessment, and the datasets generated from high resolution 
instruments can be very complicated. Currently, metabolomic profiling can be performed using 
NMR and MS technologies. However, NMR is less sensitive than MS, and requires micromole 
amounts of metabolites. Thus, MS techniques are generally preferred to identify and quantify 
metabolites in samples. Although the detection limits of these instruments can be as low as 
picomoles, none of the individual methods can cover the complete metabolome. Therefore, a 
combination of all the instruments would be ideal to ultimately measure the metabolome of a 
biological sample. A typical untargeted metabolomics workflow by GC-MS features metabolite 
extraction, metabolite derivatization, ion chromatogram overlays, data alignment, database 
identification, and validation with standards (Scalbert et al., 2009; Patti et al., 2012) (Figure 2.4). 
In contrast to the targeted metabolomics approach, untargeted metabolomics is often 
“hypothesis generating” rather than “hypothesis driven”. Hence, it is important to design the 
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experiment to ensure maximum metabolite detection and quantitative reproducibility. This 
emphasizes the importance of sample collection and preparation, chromatographic separation 
and data acquisition (Patti et al., 2012). As a global profiling approach, untargeted metabolomics 
has aided in understanding of the comprehensive relationship between cellular/whole body level 
metabolism and specific phenotypes (Fiehn and Spanger, 2002; t’Kindt et al., 2010; Patti et al., 
2012). It has also been useful in identifying key metabolites which can be targeted for 
therapeutic benefit. An example of the application of this approach is the discovery of rapid 
consumption of glycine in rapid cancer cell proliferation using LC-MS/MS (Jain et al., 2012). By 
measuring the consumption and release profiles of 219 metabolites from media across the cancer 
cell lines, glycine and related metabolites (i.e. sarcosine, serine, and threonine) were determined 
to represent a metabolic vulnerability in rapidly proliferating cancer cells. 
The challenges of untargeted metabolomics include instrument detection limits, and 
metabolite identification and quantification (Dunn et al., 2013). GC-MS is a powerful and widely 
used tool which offers high separation efficiency and reproducibility. However, it requires 
derivitization of metabolites to make them volatile for GC separation, which can be a limitation 
for large molecules. Moreover, derivatives can be easily degraded. On the other hand, LC-MS 
does not require the samples to be derivatized for analysis of polar or high molecular weight 
metabolites, but the disadvantages are the retention time instability and ion suppression (Scalbert 
et al., 2009). Unknown metabolites may be difficult to identify, thus metabolite databases and 
identification software need further improvement.  
Application of Metabolomics in Animal Sciences 
The application of metabolomics in research has increased rapidly during the past decade. 
It is expanding to catch up with other analytical techniques such as genomics and proteomics but 
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still remains far less developed and less accessible to many researchers and labs (Figure 
2.5).Although most often applied in plant science and human disease and nutrition research, the 
use of metabolomics in the animal sciences field has been increasing in recent years. It has been 
used to address questions such as the study of umbilical vein plasma metabolite differences 
between normal and growth restricted fetal pigs (Lin et al., 2011), milk metabolomics 
(Sundekilde et al., 2013) and arginine supplementation to the metabolic profile of the small for 
gestational age piglet (Getty et al., 2013). 
Mass Isotopomer Distribution Analysis  
 
Changes in one pathway may affect other pathways which seem remote from the initial 
metabolic change. Thus, it requires researchers to investigate the metabolic pathways and 
nutrient fluxes at the whole tissue or the whole animal level. The application of stable isotope 
tracer approaches in whole animals and cell cultures allows us to determine the dynamic 
processes underlying nutrient metabolism and intermediary metabolism. With the advancement 
of technologies in MS, coupled with mass isotopomer distribution analysis (MIDA), stable 
isotope tracers have been employed in a range of nutrient metabolism investigations in a variety 
of species (Brunengraber et al., 1997; Bequette et al., 2006).  
MIDA, first developed in 1991 (Katz and Lee, 1991), is a technique for measuring the 
synthesis of biological polymers (e.g. lipids, carbohydrates and proteins) (Hellerstein and Neese, 
1999). After introducing a stable isotope labeled precursor into a biological system (e.g. cell 
cultures, tissue cultures, whole animals), MIDA quantifies the relative abundance of   molecular 
species of a compound differing only in mass (mass isotopomers). The mass isotopomer pattern, 
or distribution, is analyzed using a combinatorial probability model by comparing measured 
abundances to theoretical distributions. MIDA calculates the dilution in the precursor and 
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product pools, the precursor pool turnover rate, and fractional contribution from endogenous 
biosynthesis. Generally, MIDA provides a fundamental “equation for biosynthesis” (Hellerstein 
and Neese, 1999). 










S) are particularly useful in biological 
studies. It is noteworthy that stable isotope enriched compounds are only available when the 
atom in the compound occurs naturally, 1 or 2 atomic mass units heavier.  This way, derivatized 
stable isotope enriched molecules will fragment predictably to yield an identical ion spectrum 
signature as the unlabeled (naturally abundant) compound when using GC-MS. The largest 
molecular weight fragment ion and its associated heavier isotopomers are selectively monitored 
(Bequette et al., 2006). The stable isotope labeling pattern of the targeted compound provides 
important metabolic information that extrapolates to the metabolism in the cell, tissue or whole 
organism.  
To better illustrate the above concepts, I will describe the predicted biochemical 
transformation of a [U-
13
C] labeled compound (e.g. glucose, amino acids) administration in ovo 
to developing chicken embryos as an example (Sunny and Bequette, 2010). [U-
13
C] Glucose is 
six mass units heavier, but it is metabolically indistinguishable from unlabeled glucose [M] when 
metabolized through the same pathways.  During the course of metabolism of the labeled and 
unlabelled glucose through glycolysis and the Krebs cycle, isotopomer patterns (e.g. [M+1], 
[M+2], and [M+3]) are generated in intermediates in these pathways. The relative labeling 
pattern of two intermediates can be used to derive relative contributions of metabolites towards 


























Figure 2.5 Publications of genomics, proteomics and metabolomics research from  
Year 1995-2012, data source: google scholar. 
 










































































































































C] Glucose was introduced in ovo in developing chicken embryos for three 
consecutive days to reach stable isotope steady state (Sunny and Bequette, 2010). Metabolism of 
[U-
13
C] glucose involves several initial fates: 1) incorporated into glycogen, 2) metabolized via 
glycolysis to yield [M+3] pyruvate and/or 3) entry into the pentose phosphate pathway. Further 
metabolism of [M+3] pyruvate in the Krebs cycle can lead to synthesis of [M+2] acetyl-CoA 
and/or [M+3] oxaloacetate after carboxylation.  [M+3] Oxaloacetate can either continue on 
through the Krebs cycle or be converted to [M+3] phosphoenolpyruvate which can be used to 
resynthesize glucose, thus leading to synthesis of the [M+3] glucose isotopomer. Thus, the ratio 
of [M+3] to [M+6] glucose isotopomers gives a minimal estimate of glucose carbon recycling 
and gluconeogenesis from pyruvate. However, this [M+3] glucose underestimates fractional 
gluconeogenesis due to the dilution of unlabelled carbon sources arising from: 1) entry into the 
pyruvate pool from metabolism of alanine, 2) entry of carbon sources from fatty acid β-oxidation 
and amino acid catabolism, and 3) the exchange and rearrangement of carbons due to 
oxaloacetate-fumarate cycling in the Krebs cycle, generating a mixture of 
13
C-labeled 
oxaloacetate units where carbons 1-3 and carbons 2-4 of oxaloacetate are 
13
C-labeled. Only 
oxaloacetate labeled in carbons 1-3 produces [M+3] glucose (Reeds et al., 1997).  
The 
13
C-labelling patterns of metabolites through metabolism of [U-
13
C] glucose via the 
glycolytic pathway also provide information on enzyme pathway activity (Bequette et al., 2006). 
For example, to measure pyruvate dehydrogenase (PDH) activity, the unique labeling patterns of 
intermediates from metabolism of [M+3] pyruvate in the Krebs cycle are monitored. The [M+3] 
pyruvate isotopomer generates the [M+3] oxaloacetate isotopomer via activity of pyruvate 
carboxylase (PC). Eventually, further metabolism of the [M+3] oxaloacetate in the Krebs cycle 
leads to the synthesis of [M+3] α-ketoglutarate. Moreover, the [M+3] pyruvate can also be 
33 
 
metabolized via PDH to produce [M+2] acetyl-CoA which results in the formation of [M+2] α-
ketoglutarate. However, the [M+2] α-ketoglutarate isotopomer can also result from oxaloacetate-
fumarate cycling. Here, the decarboxylation step between citrate and α-ketoglutarate leads to the 
loss of carbon 1 of oxaloacetate which contributes to the [M+2] α-ketoglutarate isotopomer, thus 
necessitating a correction to the [M+2] α-ketoglutarate enrichment (Berthold et al., 1994). In the 
study of in ovo administration of [U-
13
C] glucose described above (Sunny and Bequette, 2010), 
[M+2], [M+3] aspartate and [M+2], [M+3] glutamate enrichments were measured due to the 
technical challenges of direct measurement of tissue oxaloacetate and α-ketoglutarate 
enrichments. However, several studies have demonstrated that the isotopomer labeling patterns 
and enrichments of oxaloacetate and aspartate, and α-ketoglutarate and glutamate are nearly 
identical since these paired intermediates are in metabolic equilibrium (Katz et al., 1989; Wykes 
et al., 1998). Hence, PDH activity can be estimated by the ratio of [M+2] acetyl-CoA to [M+3] 
pyruvate (Berthold et al., 1994). 
Summary 
 
To date, several studies have evaluated the effect of egg size and breeder age on embryo 
growth and hatchability as well as other physiological parameters. However, most of these 
studies utilized different sizes of eggs from different age of hens, thus the effect of egg size on 
embryo development is often confounded with hen age. The answers to the following questions 
are not clear: 1) What is the influence of egg size or breeder age per se on embryo development? 
2) What metabolic pathway changes does the embryo undergo to satisfy the metabolic and 
growth needs of cells, tissues and organs when there is a limited supply of nutrients throughout 
development? 3) Via what mechanisms are substrate utilization adapted and coordinated when 
the embryo is faced with a limited nutrient environment (e.g. small versus large eggs)?  
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Based on the available literature and results from previous experiments in our lab, we 
hypothesized that part of the adaptation and coordination of embryo energy metabolism is 
regulated by sensing through AMPK. Eggs of different sizes and laid by hens of different ages 
affects egg nutrient composition, thus requiring metabolic adaptations to accommodate the fixed 
nutrient supply to ensure appropriate utilization of nutrients during embryo development. These 
hypotheses will be tested in this dissertation with three experiments applying metabolomics 
profiling and stable isotope MIDA approaches.  
The information generated from this project will provide information about the metabolic 
pathways that are important for embryo development. Proper pathways or metabolites may be 
determined accordingly to be biomarkers for optimal growth. Furthermore, knowledge about 
metabolic pathway changes and substrate utilization will improve our understanding of the 
nutrient needs of hatchlings. In this regard, appropriate diets could be formulated for breeders 
and hatchlings, respectively, to optimize egg content and composition to improve embryo 














CHAPTER 3: EXPERIMENT 1 
 




ENERGY-SENSING IN DEVELOPING CHICKEN EMBRYOS AND POST-HATCH 
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The objective of this study was to quantify developmental changes in macronutrients in 
eggs of different sizes, and to explore an energy-sensing mechanism that may mediate nutrient 
metabolism. We hypothesized that 5’-AMP-activated protein kinase (AMPK), a ubiquitous 
energy-sensor, plays a key role in coordinating nutrient use in developing broiler breeder 
embryos. To test this hypothesis, we measured AMPK activity in the liver of embryos, and 
carbohydrates and fatty acids in the yolk and albumen of small vs large eggs. Small (53.2 ± 1.04 
g) eggs from 26 wk-old and large (69.0 ± 1.86 g) eggs from 42 wk-old broiler breeder hens were 
acquired and measurements were made on embryonic day (e) 11, 14, 17, and 20 and on 
posthatch d1. The initial weight of dry yolk to albumen was higher (2.3 vs 1.7) in large vs small 
eggs, and embryo weight differed from e17 onwards. At set, glucose and mannose contents in 
albumen were 500-fold higher than fucose, but by e11 glucose content decreased to negligible 
levels whereas mannose and fucose contents remained constant. The proportion of palmitic and 
stearic acid in the yolk remained relatively constant during development for both egg sizes. 
However, palmitic acid accounted for a higher proportion (P < 0.0001) of yolk lipids in the small 
vs large eggs throughout development whereas linoleic and linolenic acid were 9% (P = 0.0002) 
and 22% (P < 0.0001) higher in yolk lipids from large eggs. AMPK activity was higher (P < 
0.05) in livers of embryos from large vs small eggs on each sampling day, and activity peaked 
between e12 and e20 for both size eggs. We speculate that higher AMPK activity in livers of 
embryos from large eggs may reflect increased metabolism of nutrients to support their faster 
growth rate in ovo. Taken together, our results are the first to investigate the relationship between 
liver AMPK activity and egg size and egg nutrient composition in developing chicken embryos.  
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Key words:  chicken embryo, post-hatch chicks, egg size, 5’-AMP-activated protein kinase, 
energy regulation, egg nutrient 
Introduction 
 
Broiler chicks hatched from small (< 55 g) compared to large size (65-70 g) eggs have 
greater embryonic and post-hatch mortality, and this has been linked to a lower glucose status 
and a lower ratio of yolk to albumen of smaller eggs. Chicks hatched from large eggs are heavier 
at hatch and have a larger residual yolk sac (Wilson, 1991; Lourens, et al., 2006). Lourens et al., 
(2006) reported that chicken body weight differences at hatch from small vs large eggs is due to 
the extra nutrient supply in large eggs. Given the positive correlation between egg weight and 
final hatchling weight, the economic importance of egg size is obvious (Wilson, 1991). To date, 
the mechanisms coordinating nutrient utilization in developing chicken embryos, in particular 
when egg size and nutrient composition varies, has received little attention.  
Recently, AMPK has been found to regulate energy metabolism in response to nutrient 
and hormonal signals at the cellular and whole body levels (Towler and Hardie, 2007; Lage et 
al., 2008). AMPK, a heterotrimeric enzyme complex, is composed of a catalytic (α) and two 
regulatory (β and γ) subunits (Mitchelhill et al., 1994; Stapleton et al., 1996). Activation of 
AMPK by phosphorylation of threonine 172 on α subunit enhances activity of energy-generating 
pathways such as glycolysis, fatty acid oxidation, whereas activity of energy-consuming 
pathways, for example, gluconeogenesis, fatty acid synthesis and cholesterol synthesis, is 
reduced (Kahn et al., 2005). In broilers, the expression and activity of AMPK in various tissues, 
including the liver, has been characterized for developing embryos as well as for post-hatch 
chicks (Proszkowiec-Weglarz et al., 2006; 2009). AMPK was reported to repress gene 
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expression of PEPCK, a key enzyme in gluconeogenesis (Inoue and Yamauchi, 2006). 
Furthermore, activation of AMPK was found to down-regulate energy-consuming anabolic 
enzymes at the transcriptional level (Berasi et al., 2006). In a study of the effect of fasting and 
refeeding on liver AMPK mRNA, protein and activity levels in broiler chickens, Proszkowiec-
Weglarz et al., (2009) found that phosphorylated AMPK level increased after a 48 h fast. 
More than 90% of the energy requirement of chicken embryo development was supplied 
by the yolk fatty acid oxidation (Romanoff, 1960). Embryo and liver dry matter percentages 
were shown to be associated with various fatty acids in the yolk lipid (Peebles et al., 1999). 
Carbohydrate metabolism predominates during the first week of development (Moran, 2007). In 
chicken embryos, we speculate that the differences in nutrient supply and composition of large vs 
small eggs will be reflected in coordinated changes in AMPK activity in the liver as embryos 
develop. It is unknown whether carbohydrate and fatty acid composition differ in the small vs 
large eggs and whether these nutrients are selectively used during the embryo development. 
Therefore, the objectives of this study were to measure the nutrient content (carbohydrates and 
fatty acids) in egg yolk and albumen throughout development and to investigate the effect of 
nutrient composition and content on liver AMPK activity in chicken embryos during the later 
development.  
Materials and Methods 
Egg Incubation and Sample Collection 
Fertile broiler breeder eggs of small (n = 60, 53.2 ± 1.04 g) and large (n = 60, 69.0 ± 1.86 
g) sizes from 26 and 42 wk-old hens, respectively, were acquired from Perdue Farms, Inc 
(Herlock, MD). Ten eggs from each group were randomly selected for measurements of initial 
egg composition. The remaining eggs were incubated under standard conditions of 65% relative 
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humidity and 37.5°C. On embryonic (e) day 9, eggs were candled and undeveloped eggs 
removed. On e11, e14, e17, e20 and post-hatch day 1, a hole was made into the large end (air 
cell) of the egg with scissors, the crown removed, and the air-cell membrane removed to expose 
the embryo. The embryo and connecting compartments were transferred to a petri-dish on ice. 
The weights of the embryo, and residual yolk and albumen were recorded, and the whole liver 
immediately wrapped in aluminum foil before plunging into liquid nitrogen. Livers were stored 
at -80°C. Yolk and albumen were stored at -20°C for further analysis. The experimental protocol 
was approved by the Institutional Animal Care and Use Committee at the University of 
Maryland. 
Fatty Acid Composition Analysis 
For determination of individual fatty acid concentrations, frozen yolk was lyophilized to 
dryness (FreeZone Bulk Tray Dryer, Labconco, Kansas, MO) and pulverized in a liquid nitrogen 
freezer-mill (6850 SPEX CertiPrep Freezer/Mill, Wolf, Pocklington, York).  To a known weight 
of dry yolk (50 mg) was added a known amount of a mixture of [U-
13
C] fatty acids (
13
C labeled 
algal fatty acids, Cambridge Isotope Laboratories, Inc., Andover, MA). Fatty acid methyl esters 
(FAME) were prepared using the method described by Christie (1982) and Kadegowda et al. 
(2008), with modified procedures for tissue samples. Briefly, 0.5 mL of 0.5 N NaOH/methanol 
was added to each sample and incubated in a 50°C water bath for 30 min. FAME were formed 
by adding 6.5 mL of 1.2 N H2SO4 in methanol and incubated in the dark at room temperature for 
20 h. After extraction with hexane, FAME was analyzed on a gas chromatography-mass 
spectrometer (GC-MS, HP 6890 coupled with an HP 5973 Mass Selective Detector, Agilent) 
equipped with a 60 m × 0.25 mm × 0.25 µm capillary column (DB-23, Agilent Technologies, 
Palo Alto, CA). The inlet temperature was maintained at 250°C. The GC oven temperature 
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program was: 130°C for 1 min, increase 6.5°C per min to 170°C,  increase 2.75°C per min to 
215°C,  12 min at 215°C, increase 40°C per min to 230°C and 3 min at 230°C. The MS was 
operated in electron ionization mode and ions corresponding to the unlabelled fatty acid (M) and 
the labeled fatty acid (M+n, where n is the number of carbons in the fatty acid) were monitored 
and recorded. Fatty acid concentrations were calculated by isotope dilution. 
Carbohydrate Composition Analysis 
An initial analysis of the dry yolk and albumen indicated that the predominant 







C] D-(+)-mannose and [1-
13
C] D-(+)-
fucose, Cambridge Isotope Laboratories, Inc., Andover, MA) was added to a known weight of 
sample (albumen or yolk, 75 mg) and thoroughly mixed. Samples were incubated in 10% 
trifluoroacetic acid in distilled H2O (v/v) at 105°C for 4 h.  To saturate the solution, NaCl (1 g) 
was added to each sample and the samples placed on a vortex shaker for 15 min. Cold acetone (1 
mL) was added and the samples vortex mixed for 15 min followed by centrifugation at 4,000 
rpm for 10 min at room temperature. The top acetone layer was carefully removed and blown 
down to dryness under a stream of N2 (2 psi) at 50°C. Carbohydrates were converted to their di-
O-isopropylidene mono-acetone derivative by adding 100 µL of ethyl acetate:acetic anhydride 
(v/v, 1:1) and incubating at 60
◦
C for 30 min.  Derivatized carbohydrates were separated on a 
fused silica capillary column (HP-5; 30 m × 0.25 mm × 1 µm Hewlett-Packard, Palo Alto, CA) 
prior to MS under electron ionization conditions. Ions (mass-to-charge) monitored were 287 
(unlabelled) and 293 (internal standard) for glucose, 287 and 288 for mannose, and 229 and 230 
for fucose. Carbohydrate concentrations were determined by isotope dilution. 
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Tissue Protein Extraction 
Frozen livers were homogenized in ice-cold lysis buffer containing 20mM Tris-HCl (pH 
7.5), 150 mM NaCl, 1mM ethylene glycol tetraacetic acid, 1% Triton X-100, 1 mM EDTA, 1 
mM phenylmethylsulfonyl fluoride, and 1× protease and phosphatase inhibitor cocktail (Pierce, 
Rockford, IL). The homogenate was centrifuged at 14,000 × g for 10 min at 4°C. The 
supernatant was allocated into tubes and stored frozen (-80 C). Protein concentration of liver 
extracts was measured by Bradford Assay (Bio-Rad Laboratories, Hercules, CA). 
AMPK Activity  
Enzyme-linked Immunosorbent Assay (ELISA) 
For determination of phosphorylated AMPK α level (AMPK activity), 30 µg of total 
protein was used and analyzed (AMPK α [pT 172] immunoassay kit, Invitrogen Corp., 
Camarillo, CA) according to the manufacture’s protocol. Absorbance was recorded at 450 nm 
using a microplate reader (ThermoElectron, San Jose, CA). Final AMPK activity was calculated 
using standards supplied with the kit. 
Western Blot Analysis 
Tissue lysates (50 µg) were diluted in Laemmli sample buffer prior to SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE was performed using precast Bis-
Tris 10% gradient polyacrylamide gels under reducing conditions (Bio-Rad Laboratories, 
Hercules, CA). Separated proteins were transferred to polyvinylidene fluoride membranes 
(Immobilon-P, Millipore Corp., Billerica, MA) using a semi-dry electro-blotting system (Bio-
Rad Laboratories, Hercules, CA) for 1.5 h at 80 V at 4°C. Membranes were incubated in 
blocking buffer with 5% skim milk for 2 h and immunoblotted with phosphorylated AMPK α 
(Thr172) antibody (Cell Signaling Technology, Inc. Beverly, MA), AMPK α-1 antibody 
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(Millipore Corp., Billerica, MA), and α-tubulin antibody (Santa Cruz Biotechnology, Inc.,  Santa 
Cruz, CA) at 1:1000 dilution in 5% bovine serum albumin. Membranes were washed three times 
for 10 min with TBS (0.025M Tris-HCl [pH 7.6], 0.137 M NaCl) plus 1% milk and 0.1% 
Tween-20 (TBST). Membranes were then incubated with donkey anti-rabbit horseradish 
peroxidase conjugated secondary antibody (Amersham Biosciences, Piscataway, NY) diluted in 
TBST (1:10000) at room temperature for 1 h, and then washed for 15 min in TBST and three 
times for 5min in TBS. Signals were detected with ECL plus Western blotting detection reagent 
(Amersham Biosciences, Piscataway, NY), developed and scanned using Gel documentation 
system (Bio-Rad Laboratories, Hercules, CA). AMPK α-1 and α-tubulin signal detection was 
performed after stripping the membrane with stripping buffer (100 mM 2-Mercaptoethanol, 2% 
SDS, 62.5 mM Tris-HCl pH 6.7). Densitometry was used to quantify band intensities for 
phosphorylated AMPK α, AMPK α-1 and α-tubulin. Data are expressed as the ratio of 
phosphorylated AMPK α to AMPK α-1 intensity. 
Statistical Analysis 
All data were verified to meet assumptions of normality and homogeneity of variance. 
Results were analyzed by 2-way ANOVA using PROC MIXED procedure of SAS 9.2 (SAS 
Institute Inc., Cary, NC). The fixed factors were egg size and developmental age. The statistical 
model used was Yijk = μ + Si + Tj + (ST)ij + εijk, where Yijk is kth observation from the ith size at 
the jth developmental age, μ is the grand mean, Si is the effect of ith size, Tj is the effect of jth 
developmental age, (ST)ij is the interaction between size and developmental age, and εijk is the 
error term. Where the interaction was not significant, the main effect of the individual factor was 
compared. Means were compared by Tukey-Kramer multiple comparison test, and a probability 





Prior to set, absolute weights of yolk and albumen (dry matter basis) in large eggs were 
heavier (P < 0.01) than those in small eggs (Table 3.1). And, the dry yolk to albumen ratio was 
greater in large compared to small eggs (P < 0.0001). Fresh embryo weight was greater (P < 
0.05) for large eggs from e17 onwards (Figure 3.1). Thus, chicks from large eggs were 29.9% 
heavier (P < 0.01) compared to chicks from small eggs on posthatch d1. 
Albumen and Yolk Carbohydrates 
In albumen, glucose and mannose contents prior to set were similar (25 mg/g dry weight) 
and 500-fold higher compared to fucose (Figure 3.2 a, b, c). The glucose content of albumen, 
but not mannose and fucose, decreased dramatically by e11 (~1 mg/g). Yolk glucose 
concentration did not change in large eggs from e11 to posthatch compared to the initial value (at 
set). However, surprisingly, glucose concentration increased from e17 to posthatch day 1 in yolk 
of small eggs, and these levels were greater than in large eggs at e17, e20 and posthatch d1 (P < 
0.05). Yolk mannose content did not differ between small and large eggs during most time points 

















































Small 53.2 ± 1.04  21.6 ± 0.44 7.1 ± 0.35 4.3 ± 0.24 1.7 ± 0.13 
 
1
Values are expressed as means ± SD.   
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Yolk Fatty Acid Composition 
The proportions of palmitic and stearic acids of all fatty acids in yolk remained relatively 
constant during development for both egg sizes (Table 3.2). However, palmitic and palmitoleic 
acids accounted for a higher (P < 0.0001) proportion of yolk fatty acids in small compared large 
eggs throughout development whereas the proportions of linoleic and linolenic acids were 9% (P 
= 0.0002) and 22% (P < 0.0001) higher in yolk from large eggs. Lastly, arachidonic acid 
represented a greater (P < 0.05) proportion of total fatty acids in large eggs during later 
development compared to that in small eggs. 
Liver AMPK Activity and Phosphorylation State  
For both sizes of eggs, AMPK activity (phospho-AMPK α by ELISA) was highest (P < 
0.0001) in liver of e14 embryos (Figure 3.3). There was a main effect due to egg size for liver 
AMPK activity (P < 0.05). AMPK α phosphorylation state (Western blot analysis) tended (P = 






































Figure 3.1: Fresh embryo weights of small (53.2 ± 1.04 g) and large (69.0 ± 1.86 g) eggs on 
e11, e14, e17, e 20 and post hatch day 1. Values on the figure were presented as mean ± SD, n = 




























































Figure 3.2: Initial and developmental changes in glucose (a), mannose (b) and fucose (c) content 
in dry yolk and albumen of small (53.2 ± 1.04 g) and large (69.0 ± 1.86 g) eggs. Each bar 
represents the average of ten eggs and values are expressed as the mean ± SEM.  Bars bearing 





In the current study, the initial weights of yolk and albumen as well as the ratio of yolk to 
albumen were greater in large compared to small eggs. Thus, embryos in large eggs had access to 
a greater and more energy-dense substrate supply for development and growth. As would be 
expected, embryos from large eggs were heavier compared to those from small eggs from e17 
onwards, which is consistent with our previous studies (Sunny and Bequette, 2010, 2011). 
Theoretically, embryos with the same genetic background, as in the current study, should have 
the same growth potential, irrespective of egg size. Thus, we hypothesized that the different 
nutrient environments of the two sizes of eggs would necessitate an in ovo energy-sensing 
mechanism(s) to coordinate embryo growth appropriately, and that AMPK serves this role in 
mediating changes in energy metabolism.  
The initial carbohydrate amount in the albumen was about 240 mg at time of set. The 
content of mannose in albumen remained fairly constant, whereas glucose content dramatically 
decreased by e11 compared to the value at set. These observations suggest that the embryo 
selectively metabolizes glucose up until e11 while mannose metabolism predominates up until 
hatch. Furthermore, this higher dependence on glucose metabolism for energy expenditures early 
in development is consistent with previous observations of high rates of glycolysis during this 
period (Kucera et al., 1984). It is important to note that although mannose is influential for the 
glycosylation of certain proteins in mammals (Freeze et al., 2010), mannose can be converted to 
fructose-6-phosphate for metabolism in liver cells (Alton et al., 1997).We observed higher yolk 
glucose concentration at later development, which was consistent with another study (Yadgary et 
al., 2010). Surprisingly, yolk glucose concentration was observed to be higher in small eggs on 
e17, e20 and posthatch day 1, which suggests greater gluconeogenesis than that in large eggs. 
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Yadgary et al., (2010) showed that carbohydrate synthesis in the yolk sac, and the amount of 
carbohydrate reached the peak by e19. Increased yolk glucose content provides available energy 
for chicken embryo during hatching and pipping.  Fucose is a common component of glycans 
and glycolipids in nearly all species. Through a nucletotide-activated form, GDP-fucose is 
essential in the construction of fucosylated oligosaccharides and can also be transformed from 
GDP-mannose (Becker and Lowe, 2003).The concentration of fucose in the yolk and albumen in 
our current study did not change during development. This phenomenon is not surprising 
because fucose-containing glycan has important roles in blood transfusion reactions and 
numerous ontogenic events (Becker and Lowe, 2003). The embryo must maintain a constant 
concentration of fucose for the high demand of embryogenesis during development. 
The proportions of linoleic, linolenic, and arachidonic acid in total fatty acids were higher 
in the yolk of large egg at set, and thus development of the embryos in large eggs was aided by a 
greater supply of essential fatty acids (EFA). The greater absolute and relative availability of 
these three EFAs in the yolk of large eggs may allow for optimal embryonic growth and 
hatchability.  
We observed higher liver AMPK activity from e11 to post-hatch day 1 in large egg 
embryos. The higher AMPK activity in liver of the large egg embryos may serve to enhance 
activity of pathways that generate energy to fuel their higher rate of growth during the later 
stages of development compared to the small egg embryos. This view is in agreement with our 
previous observations (Sunny and Bequette, 2010) where blood amino acid (glycine, glutamine, 
valine, leucine, isoleucine, threonine, arginine and tyrosine)  concentrations were higher in large 
embryos on e16 and e18, suggesting a greater availability of amino acids for the higher rates of 
tissue protein synthesis needed to support this increased growth rate. Furthermore, by e20, the 
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large egg embryos had metabolized a larger (+6.2 % more) proportion of their original yolk 
weight as compared to small egg embryos. The higher yolk glucose content in the small eggs 
may indicate greater gluconeogenesis at the last several days of development. This again 
demonstrated higher AMPK activity in large egg embryos may suppress the energy-consuming 
pathways, which result in a lower glucose concentration in the yolk of large eggs.   
Liver AMPK activity was at its highest on e14 in embryos from both size eggs.  
Similarly, AMPK activity was found to be highest in liver of chicken embryos on e16 
(Proszkowiec-Weglarz and Richards, 2009). That study measured AMPK activity on e12, e16, 
e20 and post-hatch day 1, whereas in our study activity was measured on e11, 14, e17, e20 and 
post-hatch day 1, hence, giving a better resolution of AMPK activity during later development. 
Overall, the high liver AMPK activity from e12 to e20 reflects the period of embryo 
development when growth rate is highest and thus when energy demands are greatest (Sato et al., 
2006; Moran, 2007). 
AMPK activity as determined by Western blot analysis was expressed as the ratio of 
phospho-AMPK α to AMPK α-1 band intensity whereas the ELISA method measures phospho-
AMPK α (Thr172) amount. Studies have shown that chicken liver preferentially expresses the 
AMPK α-1 subunit (Proszkowiec-Weglarz et al., 2006), unlike mammals which express both α-1 
and α-2 subunits that contribute roughly equally to total AMPK activity in liver (Woods et al., 
1996). Therefore, the AMPK α-1 antibody was preferred instead of AMPK α (α-1 and α-2) since 
the former is 94% homologous between mammals and chickens (Proszkowiec-Weglarz and 
Richards, 2009), and thus is the most suitable commercial product available. Western blot 
analysis of AMPK phosphorylation state followed a similar pattern (peaking between e12 and 
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e20) to that of the ELISA results; however, larger within group variation for the Western blot 
analysis precluded detection of statistical differences.  
This study is the first to link embryonic liver AMPK activity with different nutrient 
compositions of broiler breeder eggs. Further studies are required to investigate whether specific 
substrates link AMPK activity and nutrient utilization in ovo, and the metabolic mechanisms that 
underlie coordination of egg nutrient use during embryo development.
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Table 3.2: Fatty acid composition in the yolk at set (e0), and from e11 to posthatch day 1 of development
1
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      1
 Results are presented as percentages of all fatty acids measured. 
      2
 Time effect refers to day of incubation effect.  
      3 
NS = Not significantly different 

















































Figure 3.3: AMPK activity in liver of small and large egg embryos determined by ELSIA. Bar 
values (n = 4) are expressed as the mean ± SEM of phospho-AMPK α level. Bars bearing 














Figure 3.4: Representative Western blot of phospho-AMPK α, AMPK α-1, and α-tubulin in 
liver of small and large egg embryos.  
 
 


































Figure 3.5: Quantitative results from Western blots. Bar values (n = 4) were expressed as the 


















METABOLOMIC PROFILING IN DEVELOPING CHICKEN EMBRYOS AND 
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The aim of this study was to apply a metabolomic profiling approach to determine the 
influences of breeder age (32 wk vs 51 wk-old hens) and egg size (small vs large) and 
composition on developmental patterns of metabolism in embryos and posthatch chicks. Results 
showed that the proportions of palmitic and palmitoleic acids in the yolk of eggs from 32 wk-old 
hens were higher than those from 51 wk-old hens prior to set and throughout development in the 
residual yolk. Oleic and linolenic acids accounted for a higher proportion of yolk fatty acids in 
eggs from 51 wk-old hens at each developmental age that was evaluated. Gas chromatography-
Mass spectrometry (GC-MS) was employed to evaluate the metabolome of the liver and blood of 
embryos on embryonic (e) days e14, e17 and e20 and on posthatch day 1. Principal component 
analysis (PCA) revealed that e14 and e20 liver metabolites, and e14 blood metabolites formed 
two separate clusters corresponding to 32 wk and 51 wk-old hens. However, clear separation of 
liver and blood metabolites was not observed in embryos from small vs large eggs at any 
developmental age. Pathway analysis on e14 and e20 liver metabolites in embryos from two ages 
of hens featured differences in branched-chain amino acid (BCAA), glycine, serine and threonine 
metabolisms (P < 0.05). Moreover, using PCA and hierarchical clustering analysis (HCA), it was 
observed that liver metabolites in embryos from either 32 wk or 51 wk-old hens formed four 
clusters in relation to the four developmental ages. The closer clusters corresponded to liver 
metabolites from e14, e17 and e20 embryos, whereas the posthatch day 1 liver metabolites 
clustered separately from the other clusters. The synthesis and degradation of ketone bodies, and 
glycerolipid and glutathione metabolism were the unique pathways that significantly differed 
during development in embryos from 51 wk-old hens. Overall, this study represents the first 
application of a metabolomic profiling approach to globally detail embryo metabolism and to 
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systematically evaluate the influences of hen age and egg size on embryo metabolism and growth 
during later development.  The results from this study indicate a number of implications 
regarding the influences of maternal age and nutrient environment on overall development of the 
chicken embryo and posthatch chick.  
Key words: hen age, egg size, GC-MS, metabolomic profiling, embryo metabolism 
Introduction 
 
Greater embryo and posthatch mortality are associated with broiler chicks from small (< 
55 g) compared to large eggs (65-70 g). Studies have shown that broiler breeder age influences 
subsequent embryo development and hatchability (Shanawany, 1984; O’Sullivan et al., 1991; 
Latour et al., 1996, 1998; Ulmer-Franco et al., 2010).  Yolk deposition in the egg (Peebles et al., 
2000) and egg size (Suarez et al., 1997) increase with the age of hen. However, hen age is not the 
only factor that contributes to egg size differences. Other contributors include nutritional status 
(hen diet), breed and physiological status of the hen (Surez et al., 1997; Mortola and Awam, 
2010). Egg size is positively correlated with subsequent poult weight in both broiler chickens 
and turkeys (Reinhart and Moran, 1979; Shanawany, 1987). The average chick weight at hatch is 
approximately 68% of the initial egg weight (Shanawany, 1987). The proportion of egg nutrient 
components, however, does not increase in proportion to egg weight. A study in turkeys found 
that by 24 wks of age, egg weight increased by about 11% compared to eggs laid at the onset of 
the lay period (Reidy et al., 1994), whereas the increases in yolk and albumen weight were 21% 
and 7% respectively.  The yolk to albumen ratio was found to be higher in eggs from older hens 
compared to eggs from younger hens (Shanawany, 1984; Wilson, 1991; Applegate and Lilburn, 
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1996). Further, the smaller eggs laid in the clutch have a greater proportion of yolk than the 
larger eggs in the clutch from the same hens (Vieira and Moran, 1998). 
Embryos from young breeders are associated with inefficient yolk lipid mobilization, 
transport and metabolism (Noble et al., 1986; Yafei and Noble, 1990). In addition, McNaughton 
et al., (1978) reported a higher mortality rate (2.4%) during 8 wks of growth in chicks from 29 
wk vs 58 wk-old broiler breeders. This higher mortality rate occurred in the poults hatched from 
small eggs (47-54 g) by young hens (29 wk). This may reflect the less developed physiological 
systems of younger hens. In contrast, embryos from very old breeders have less hepatic and 
cardiac glycogen stores. Plasma glucose and thyroxine (T4) concentrations are lower in embryos 
from old hens (Christensen et al., 1996). To date, there have been few studies that have 
investigated the independent influences of hen age and egg size (Shanawany, 1984; Applegate 
and Lilburn, 1996; Ulmer-Franco et al., 2010) on embryo metabolism, growth and physiology. 
Small eggs from young hens were used in most studies which might result in confounded effects 
of maternal age and egg size.  
Metabolomics is an emerging field that uses diverse high-throughput analytical 
platforms, such as NMR, LC-MS/MS, GC-MS to provide an unbiased qualitative and 
quantitative assessment of the complete set of metabolites produced by an organism at a certain 
physiological state.  Compared to other ‘omics’ approaches, metabolomics has numerous 
benefits. For instance, it reflects instantly the system perturbations in the metabolome that can be 
related to biochemical and phenotypic changes in the system (Dunn et al., 2011). Metabolomics 
has offered new perspectives in the animal science field, allowing scientists to investigate the 
metabolic pathway network changes in response to diet, physiological state, and disease to name 
a few. Thus far, the number of studies that have used metabolomic profiling approaches to 
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address questions of animal nutrition and production are still relatively few. With limited 
applications in pig and dairy cow studies, there is still no report about the utilization of 
metabolomic profiling in the chickens. Hence, in this study, we hypothesized that hen age and 
egg size would influence embryo metabolism, which may ultimately lead to differences in 
development and physiology of the embryo and posthatch chick.            
Materials and Methods 
Egg Incubation and Sample Collection 
The experimental protocol (R-13-32) was approved by the Animal Care and Use 
Committee of the University of Marylan. 
Fertile eggs from broiler breeders of different ages (Exp. 1: 32 wk, n = 60 vs 51 wk, n = 
60, same egg weight, 63.2 ± 1.1 g,) and of two sizes laid by 45 wk old breeders (Exp. 2: 55.8 ± 
1.2 g, n = 60 vs 67.7 ± 1.1 g, n = 60) were acquired from Perdue Farms, Inc (Salisbury, MD). 
Ten eggs from each group were randomly selected for measurements of initial egg composition. 
The remaining eggs were incubated under the standard condition of 65% relative humidity and 
37.5°C. On embryonic (e) day 9, eggs were candled and undeveloped eggs removed. On e11, 
e14, e17, e20 and post-hatch day 1, a hole was made into the large end (air cell) of the egg with 
scissors, the crown removed, and whole egg contents were carefully transferred to a petri-dish on 
ice. The vitelline vessels (artery and vein) were exposed on the top and clearly visible. Embryos 
were bled by making a nick across the vitelline vessels and blood was drawn using a glass 
pasture pipette. Blood was transferred to a 600-µL blood collection tube with a solid lithium 
heparin ring (Multivette
®
, Sarstedt AG & Co., Nuembrecht, Germany). The weights of embryos, 
and residual yolk and albumen were recorded, and the whole liver immediately wrapped in 
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aluminum foil before plunging into liquid nitrogen. Livers and blood samples were then stored at 
-80°C. Yolk and albumen were stored at -20°C for later analysis. 
Fatty Acid Composition Analysis 
For determination of individual fatty acid concentrations, frozen yolk was lyophilized to 
dryness (FreeZone Bulk Tray Dryer, Labconco, Kansas city, MO) and later pulverized into a fine 
powder for analysis. To a known weight of dry yolk (50 mg), was added a known amount of a 
[U-
13
C] fatty acid mixture (
13
C labeled algal fatty acids, Cambridge Isotope Laboratories, Inc., 
Andover, MA). Fatty acid methyl esters (FAME) were prepared using the method described by 
Christie, (1982) and Kadegowda et al., (2008), with modified procedures for tissue samples. 
Briefly, 0.5 mL of 0.5 N NaOH/methanol was added to each sample and  incubated in a 50°C 
water bath for 30 min. FAME were formed by adding 6.5 mL of 1.2 N H2SO4 in methanol and 
incubated in the dark at room temperature for 20 h. After extraction with hexane, FAME were 
analyzed on a gas chromatography-mass spectrometer (GC-MS, HP 6890 coupled with an HP 
5973 Mass Selective Detector) equipped with a 60m × 0.25mm × 0.25µm capillary column (DB-
23, Agilent Technologies, Palo Alto, CA). The inlet temperature was maintained at 250°C. The 
GC oven temperature was: 130°C for 1 min, increased at 6.5°C per min to 170°C, increase 
2.75°C per min to 215°C and held for 12 min, increased at 40°C per min to 230°C and held for 3 
min. Ions corresponding to the unlabelled fatty acid (M) and the labeled fatty acid (M+n, where n 
is the number of carbons in the fatty acid) were monitored and recorded. Fatty acid 





Untargeted Metabolomic Profiling 
Sample Preparation 
Blood and liver samples were processed according to Want et al., (2006), Pasikanti et al., 
(2008) and Kouremenos et al., (2010) with modifications. Briefly, two liver samples were pooled 
(60 mg), and to the sample was added a known weight of L-norleucine (200 µL, 1.0 mg/mL, 
freshly prepared and stored at 4
◦
C, Tokyo Chemical Industry Co., Ltd, Tokyo, Japan). Samples 
were extracted with 1 mL of ice-cold mixture of distilled H2O:CH3OH:CHCl3 (2:5:2, v/v/v) in an 
ice-bath using a hand held homogenizer (VWR PowerMax AHS 200, VWR International, 
Radnor, PA). The homogenates were centrifuged at 15,000 × g for 15 min at 4 
◦
C, and the 
supernatant reduced to dryness under N2 gas at room temperature. To the dried extract, 80 µL of 
methoxylamine hydrochloride (15 mg/mL, 98% purity, Sigma-Aldrich Co. LLC., St. Louis, MO) 
in pyridine and 80 µL of N,O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1% 
trimethylchlorosilane (TMCS, Supelco, Sigma-Aldrich Co. LLC) were added, and the samples 
were vigorously vortexed. Derivatization of metabolites was carried out by microwaving for 90 
sec at 200 watts prior to GC separation and MS analysis.  
For blood samples, a known weight of internal standard (50 µL of L-norleucine, 0.33 
mg/mL) was added to a known weight (50 mg) of blood. Blood metabolites were extracted with 
1 mL ice-cold methanol. Samples were gassed with N2 and vortexed vigorously for 15 min, 
followed by centrifugation at 13,400 × g for 10 min at room temperature. The supernatant was 
carefully transferred to a v-vial and reduced to dryness under N2 gas at room temperature. 
Derivatization of metabolites was carried out by adding 40 µL of methoxylamine hydrochloride 
(30 mg/mL, Sigma-Aldrich Co. LLC.) in pyridine and 40 µL of BSTFA (1% TMCS) (Supelco, 
Sigma-Aldrich Co. LLC), then the samples were sealed and vortexed vigorously. To expedite 
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derivatization, samples were microwaved for 90 sec at 200 Watts prior to GC separation and MS 
analysis. 
GC-MS Analysis 
The trimethylsilyl derivatives were separated by GC with a a 30m × 0.25mm × 0.25µm 
capillary column (HP 50+, J&W Scientific, Agilent Technologies, Palo Alto, CA). The front 
inlet temperature was maintained at 250°C.  The initial GC oven temperature was 70°C for 5 
min, increased at 5°C per min to 310°C and held for 5 min, and 40°C per min to 70°C and held 
for 5 min. The MS was operated in electron impact mode and analyte ions were monitored in full 
mode. ChemStation Data Analysis software (Version Rev.D.01.02; Agilent Technologies) was 
used for manual review of chromatograms and ion spectra and quantification of ion intensity. 
Representative ion areas of each compound were corrected by using the internal standard ion 
158.0.  
Metabolite Identification 
Classification and identification of metabolites were performed using the NIST mass 
spectral library with search program (2008) and Agilent Fiehn GC/MS metabolomics RTL 
library (2008). Metabolites were confirmed by both retention time and mass spectra in the 
library. Match probability over 60% was considered to be the corresponding compound.  Missing 
values were assumed to result from areas falling below the instrument detection limits. 
Statistical Analysis 
Embryo body, egg content, and egg shell weights, and fatty acid composition are 
expressed as means ± SD or mean ± SEM and analyzed by 2-way ANOVA using PROC MIXED 
procedure of SAS 9.2 (SAS Institute Inc., Cary, NC). For eggs of different sizes, the fixed factors 
were egg size and developmental age. The statistical model used was 
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Yijk = μ + Si + Tj + (ST)ij + εijk,  
where Yijk is the kth observation from the ith size at the jth developmental age, μ is the 
grand mean, Si is the effect of ith size, Tj is the effect of jth developmental age, (ST)ij is the 
interaction between size and developmental age, and εijk is the error term. For eggs of the same 
weight, but from different ages of hen, the fixed factors were maternal age and developmental 
age. The statistic model used was 
Yijk = μ + Ai + Tj + (AT)ij + εijk, 
where Yijk is kth observation from the ith hen age at the jth developmental age, μ is the 
grand mean, Ai is the effect of ith age, Tj is the effect of jth developmental age, (AT)ij is the 
interaction between maternal age and developmental age, and εijk is the error term. Where the 
interaction was not significant, the main effects of the individual factor were compared. Means 
were compared by Tukey-Kramer multiple comparison test, and a probability of P < 0.05 was 
considered statistically significant.  
Data mining and multivariate statistic analysis of metabolomics profiling data were 
performed using MetaboAnalyst 2.0 (http://www.metaboanalyst.ca) (Xia et al., 2009, 2011, 
2012) and XCMS online (https://xcmsonline.scripps.edu/). The data were semi-quantitative, and 
fold changes were compared between groups. Data was first normalized by log transformation 
and scaled by Pareto Scaling. Transformed data within different hen age at each embryonic 
developmental age or within two egg sizes at each developmental age were compared using a 
Student’s t-test. Principal component analysis (PCA) was employed to identify the relationships 
between classes of transformed data. A loading plot was constructed to show the variables 
(metabolites) responsible for the variation within the dataset and correlations among the 
individual metabolites corresponding to the first two principal components (PC1 and PC2). 
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Hierarchical clustering analysis (HCA) with Euclidean distances measures and Ward’s linkage 
were performed to explore the presence of clustering patterns among all the samples. Identified 
metabolites were applied to MetaboAnalyst 2.0 to perform pathway analysis using the Kyoto 




Initial yolk weight (dry matter basis) was heavier (P < 0.01) in eggs from 51 wk vs 32 
wk-old hens whereas the albumen weight was heavier (P < 0.05) in eggs from 32 wk vs 51 wk-
old hens (Exp. 1) (Table 4.1). And, the yolk to albumen ratio was higher (P < 0.01) in eggs from 
51 wk-old hens. However, both embryo and liver weights did not differ between different age 
breeders throughout later development (Figure 4.1 a, c).  
For eggs of different sizes, but from the same age (45 wk) of hens (Exp. 2), the weights 
of yolk and albumen prior to set were heavier (P < 0.01) in large compared to small eggs (Table 
4.1). The yolk to albumen ratio tended (P = 0.067) to be lower in the large eggs, and their 
embryo weight was greater from e20 through posthatch day 1. Liver weight differences followed 
the same pattern as embryo weight (Figure 4.1 b, d).  At hatch, chick weight was 26.6% greater 
for large compared to those from small eggs.  
Yolk Fatty Acid Composition  
The proportions of both palmitic and palmitoleic acids in egg yolks from 32 wk-old hens 
were higher (P < 0.01) than those from 51 wk-old hens at set (e0) and this pattern remained 
throughout  development (Table 4.2). However, oleic and linolenic acids accounted for a higher 
proportion (P < 0.01) of yolk fatty acids for eggs from 51 wk-old hens at each developmental age 
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that was monitored. For both ages of breeders, the rate of yolk utilization oleic acid was less at 
e20 and posthatch day 1 compared to the earlier developmental ages. Relatively more yolk 
linoleic acid was mobilized for embryo use closer to hatch (P < 0.01).  
The pattern of yolk fatty acids in small and large eggs from 45 wk-old hens did not differ 
throughout development (Table 4.3). The proportion of yolk palmitic acid was highest in both 
sizes of eggs on day 1 posthatch. In contrast, the proportions of myristic, myristoleic, oleic, 
stearic, and linolenic acids were highest on e20 and posthatch day 1 compared to e0 and earlier 
developmental ages (e11- e17). 
Liver Metabolic Profiling  
Hen age (32 wk vs 51 wk) 
Based on PCA analysis, global liver metabolites clustered separately for embryos from 
32 wk vs 51 wk-old hens on both e14 and e20 (Figure 4.2a, Figure 4.3a). Data were visualized 
by constructing PC scores, where each point on the plot represented a single sample (pooled by 
two original samples). Liver samples from e11 embryos were not included in this analysis due to 
insufficient replication. For e14 liver metabolites, PC1 and PC2 represented 45 and 21.1% of 
variation, respectively. The first two PC explained 68.5% of the total variance within the data for 
e20 embryos. However, we did not observe group separation for liver metabolites on e17 and 
posthatch day 1 (Appendix a, b). 
Loading plots (Figures 4.2 b and 4.3 b) showed the individual liver metabolites 
responsible for the variation of the first two eigenvalues (PC1 and PC2). Metabolites with the 
similar distance from 0 and with the same direction are positively correlated, and those in the 
opposite direction are negatively correlated. For e14 liver samples, palmitic, stearic and linoleic 
acids, the BCAA, phenylalanine, glutamine, glycerol and lactate were positively correlated with 
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each other for PC1.  However, these metabolites were negatively correlated with succinate, 
glycine, threonine and oleic acid.  For PC2, a contrast appears to exist between succinate, 
threonine, aspartate and the BCAA as well as for β-hydroxybutyric acid.  Oleic acid appears to 
be an important metabolite influencing the separation for both PC. For e20 liver metabolites, the 
first PC highlights the contrast between alanine, aspartate, uridine and several fatty acids. The 
second PC shows the contrast between glycine, threonine, succinate, malate, cholesterol and 
glycerol as well as pyrimidine.  
A widely used pattern recognition method, partial least squares regression discriminant 
analysis (PLS-DA), was carried out to construct and validate the classification model. The results 
from PLS-DA on e14 and e20 liver metabolites showed clearly distinct groups in clustering 
between eggs derived from 32 wk and 51 wk-old hens (Figure 4.4 a, b).  
Pathway analysis showed that 16 metabolic pathways in e14 embryo livers and nine 
pathways in e20 embryo livers were different for embryos from 32 wk vs 51 wk-old hens (P < 
0.05) (Tables 4.4 and 4.5). Metabolic pathways that differed in e14 and e20 embryos mainly 
involve amino acid and glucose metabolism. Although some of the fatty acids, i.e., palmitic, 
oleic and linoleic acids, contribute to the differences in embryos from 32 wk vs 51 wk- old hens 
shown on the loading plots, they were not involved in the metabolic pathways that were 
significantly different between the two ages of breeders in the current study.  
Egg size (small vs large)  
PCA results did not show group separation in liver metabolites of embryos from small vs 



























        
Exp. 1 32  62.9 ± 1.2 21.8 ± 0.5 8.8  ± 0.6
**
 4.9 ± 0.4
*
 1.8 ± 0.3
**
 8.8 ± 0.4 
 51  62.8 ± 1.0 22.6 ± 1.0 9.6  ± 0.7 4.5 ± 0.3 2.1 ± 0.2 8.7 ± 0.6 
        
Exp. 2 45  55.8 ± 1.2
**
 23.2 ± 1.0 9.1  ± 0.6
**
 3.9 ± 0.3
**
 2.4 ± 0.3 9.1 ± 0.4 
 45  67.7 ± 1.1 22.7 ± 0.5 10.4 ± 0.6 5.0 ± 0.4 2.1 ± 0.3 9.0 ± 0.5 
 
           1
Values are expressed as means ± SD, comparisons were made within Exp. 1, 32 wk (n = 60) vs 51 wk (n = 60); Exp. 2, small  
         (n = 60) vs large (n = 60) eggs.   
           2 












Figure 4.1: Embryo weights from e11 to posthatch day 1. a. Embryo weights in eggs of the same 
size but from different age hens (32 wk vs 51 wk); b. Embryo weights in large vs small eggs 
from 45 wk- old hens (Exp. 2); c. Liver weights of embryos from the same size eggs but different 
ages of hens (32 wk vs 51 wk; Exp. 1); d. Liver weights of embryos from small vs large eggs 
from 45 wk- old hens (Exp. 2). Values on the figures were presented as means ± SD, n = 8-10 at 
each developmental age, * P < 0.05, ** P < 0.01. 
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Table 4.2: Yolk fatty acid composition of eggs from 32 wk and 51 wk-old hens at set (e 0), and on e11 to posthatch day 1 








































































































32 wk 2.6 2.8 2.4 2.3 2.6 2.5 0.07 NS 0.003 
51 wk 2.1 2.4 2.5 2.1 2.2 2 0.07 
Stearic acid 
C18:0 
32 wk 7.0 6.8 6.8 7.1 6.7 7.2 0.08 NS NS 






















































































           a,b,c,d
 Values within a row bearing different superscript letters differ (P < 0.05), NS = Not significantly different.
 
           1 
Results are presented as percentages of all fatty acids measured. 
           2
 No interaction exists between hen age effect and time effect. 
           3




Table 4.3: Yolk fatty acid composition of small vs large eggs (45 wk) at set (e 0), and on e11 to posthatch day 1 (Exp. 2)
1
 











 Size effect 
Myristic acid 
C14:0 
small 0.20a 0.23a 0.21a 0.24a - 0.34b 0.009 <0.0001 NS 
large 0.19a 0.24a 0.18a 0.22a 0.25 0.34b 0.009 
Myristoleic acid 
C14:1 n-9 
small 0.02a 0.04a 0.02a 0.03a - 0.08b 0.003 <0.0001 NS 
large 0.02a 0.04a 0.02a 0.02a 0.05 0.08b 0.004 
Palmitic acid 
C16:0 
small 22.2ab 22.2a 23.1b 22.4ab - 20.6a 0.199 0.0003 NS 
large 22.5b 21.9a 21.8ab 21.9ab 21.5 20.4a 0.207 
Palmitoleic acid 
C16:1 n-7 
small 2.3 2.5 2.6 2.5 - 1.9 0.076 NS NS 
large 2.3 2.2 2.2 2.2 2.3 2.1 0.061 
Stearic acid 
C18:0 
small 6.8ab 6.9ab 6.4a 6.8ab - 7.4b 0.082 <0.0001 NS 
large 6.5a 7.5b 6.5a 6.6a 6.7 7.6b 0.096 
Oleic acid 
C18:1 n-9 
small 59.6ab 57.7ab 57.7b 58.4ab - 60.9a 0.308 0.0062 NS 
large 58.6ab 58.6ab 60.4ab 59.5ab 60.1 60.9a 0.321 
Linoleic acid 
C18:2 n-6 
small 8.8 10.2 9.8 9.4 - 8.4 0.23 NS NS 
large 9.7 9.3 8.6 9.3 8.9 8.4 0.183 
Linolenic acid 
C18:3 n-3 
small 0.19a 0.26b 0.19ab 0.22ab - 0.24ab 0.008 0.0072 NS 
large 0.20ab 0.23ab 0.22ab 0.22ab 0.21 0.24ab 0.006 
 
a,b 
Values within a row bearing different superscript letters differ (P < 0.05), NS = Not significantly different.
 
1 
Results are presented as percentages of all fatty acids measured. 
2
 e20 yolk fatty acids from small eggs were not quantified due to the limited amount of internal standards.  
3
No interaction existed between hen age and time effects. 
4




Liver metabolism during development (e14-posthatch day 1) 
PCA and HCA were performed on liver metabolites in embryos from 32 wk and 51 wk-
old hens (Exp. 1) and from two egg sizes (45 wk-old hens, Exp. 2) to investigate shifts in embryo 
liver metabolism. The PCA results on liver metabolites of embryos from 32 wk-old hens 
revealed the presence of four clusters corresponding to each developmental age, with metabolite 
clusters on e17 and e20 overlapping (Figure 4.5a). The first two PC represented 73.1% of the 
total variation. Likewise, PCA results of embryo liver metabolites from 51 wk-old hens showed 
clear separation amongst the four developmental ages (Figure 4.5b). On the PCA score plot, 
83.8% of the total variation was explained by the first two PC. 
For small and large eggs from 45 wk-old hens, results indicated that for embryos from the 
small eggs, there were two clusters corresponding to e14 and e17 liver samples. However, the 
separations of e20 and posthatch day 1 livers were not evident (Figure 4.6a). The distinct 
separation of liver metabolites from large eggs corresponded to the four developmental ages 
which is clearly shown on the PCA score plot (Figure 4.6b).The results of HCA are graphically 
presented in Figures 4.7- 4.10. The dendrograms show the presence of different sub-clusters of 
individual samples and of different metabolites with various degrees of similarity.  The levels of 
different metabolites (variable) with respect to developmental age are indicated with the color 
intensity change on the heat map. The individual samples or different metabolites with higher 
similarity are positioned together with shorter branch heights. The HCA in the current study 
shows four clusters corresponding to the four developmental ages for embryos from both 32 wk 
and 51 wk-old hens. Similarly, four clusters were formed for e14, e17, e20 and posthatch day 1 
liver metabolites in embryos from large eggs derived from 45 wk-old hens.  Although there were 
four clusters presented on the dendrogram for embryos from small eggs (45 wk-old hens), one 
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e20 sample did not cluster with the other e20 liver metabolite samples, which might indicate the 
existence of an outlier. Interestingly, the HCA revealed the presence of three clusters of 
metabolites for embryos from both 32 wk and 51 wk-old hens. One cluster of metabolites 
consisting of arachidonic acid, alanine, proline, serine and glucose showed a clear increase with 
embryo development whereas another cluster consisting of palmitic and stearic acids, and 
leucine, glutamine and succinate reflected a decrease with advancing developmental age. 
However, the clustering of liver metabolites in embryos from small and large eggs derived from 
45 wk-old hens was not as distinct. To elucidate the metabolic pathways that shift in activity and 
to investigate whether hen age and egg size affect developmental metabolism, pathway analysis 
was performed on liver samples on e14, e17, e20 and posthatch day 1 from 32 wk and 51 wk-old 
hens (Exp. 1), and on small and large eggs from 45 wk-old hens (Exp. 2), respectively.  For 
embryos from 32 wk-old hens, the metabolic pathways that were significantly different with 
advancing developmental age included amino acid metabolism (P < 0.05), in particular glycine, 
serine and threonine metabolism, and fatty acid biosynthesis, energy-related metabolism and 
nucleotide metabolism (Table 4.6). While the metabolic pathways that differed in embryo livers 
from 51 wk-old hens included the same categories of metabolism as those from 32 wk-old hens 
(Table 4.7), differences in several pathways were unique to embryos from 51 wk-old hens (P < 
0.05), most notably synthesis and degradation of ketone bodies, and glycerolipid and glutathione 
metabolism. 
The pathways that contributed to the developmental changes in metabolism of embryos 
from small and large eggs (45 wk-old hens) featured amino acid, fatty acid and energy-related 
metabolism (P < 0.05) (Tables 4.8 and 4.9). However, developmental shifts in steroid 
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biosynthesis, and glycerolipid, cysteine and methionine metabolism were unique to embryos 
from large eggs. 
Blood Metabolic Profiling 
Hen age (32 wk vs 51 wk) 
PCA analysis of blood metabolites revealed group separation on e14 (Figure 4.11a) but 
not on e17, e20 nor posthatch day 1 (Appendices g, h, i). The first two PC for e14 blood samples 
explained 65.2% of the total variation. Loading plot results revealed a contrast between β-
aminoisobutyric acid, aspartate, methionine, linoleic acid and β-hydroxybutyric acid as well as 
glycine for PC1 (Figure 4.11b). PC2 featured the contrast between BCAA and glycerol.  
We further performed pathway analysis to identify the pathways that contributed to the 
differences in e14 embryo metabolism in eggs from 32 wk vs 51 wk-old hens (Table 4.10). 
These results indicated differences in BCAA and glycerolipid metabolism, and fatty acid 
biosynthesis and metabolism. 
Egg size (Small vs Large) 
PCA was applied to investigate whether the metabolism of embryos differed due to egg 
size. Separation of blood metabolites on e14, e17, e20 and posthatch day 1 from small vs large 









Figure 4.2 Principal component analysis (PCA) of e14 liver metabolomic profile (Exp. 1). a. The PCA score plot distinguishes the 
metabolic profiles of liver metabolites in eggs from 32 wk (Δ) vs 51 wk (+) old hens on e14. The first three characters represent the 
embryo developmental age (e14) followed by age (32 wk, 51 wk) and replicates (1-5 samples). b. Loading plot shows the correlations 
among individual liver metabolite of PC1 and PC2 (eigenvalues). Variables (metabolite) with the same distance from zero with similar 





Figure 4.3 Principal component analysis (PCA) of e20 liver metabolomic profile (Exp. 1). a. The PCA score plot distinguishes the 
metabolic profiles of liver metabolites in eggs from 32 wk (Δ) vs 51 wk (+) old hens on e20. The first three characters represent the 
embryo developmental age (e14) followed by age (32 wk, 51 wk) and replicates (1-5 samples). b. Loading plot shows the correlations 
among individual liver metabolite of PC1 and PC2 (eigenvalues). Variables (metabolite) with the same distance from zero with similar 





Figure 4.4 Partial least squares-discriminant analysis (PLS-DA) of e14 and e20 liver metabolites (Exp. 1). a. PLS-DA score plot 
shows clear group clustering in e14 liver metabolites from 32 wk vs 51 wk-old hens. b. PLS-DA score plot discriminates e20 liver 







Table 4.4 Liver metabolic pathways that were significantly different in e14 embryos from 32 wk 







Propanoic acid metabolism Succinate <0.0001 0.0021 
Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, Threonine 
0.00012 0.0021 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
0.00020 0.0021 
Citrate cycle (TCA cycle) Succinate, Malate 0.00021 0.0021 







Pantothenate and CoA biosynthesis Valine 0.00046 0.0032 
Alanine, aspartate and glutamate metabolism Succinate, Aspartate, 
Aspargine, Glutamine 
0.00130 0.0075 
Glycine, serine and threonine metabolism Serine, Glycine, 
Threonine 
0.00401 0.0183 
Phenylalanine, tyrosine and tryptophan metabolism Phenylalanine 0.00744 0.0278 
Glutathione metabolism Glycine 0.020 0.0592 
Lysine degradation Lysine 0.022 0.0592 
Biotin metabolism Lysine 0.022 0.0592 
Pyruvate metabolism Lactate, Malate 0.034 0.0874 
Fructose and mannose metabolism Glucitol 0.036 0.0874 
Glycolysis or Gluconeogenesis Glucose, Lactate  0.048  0.110 
 
1 
Metabolic pathways that are different based on normalized e14 liver metabolite data in eggs 
from 32 wk vs 51 wk-old hens. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3










Table 4.5 Liver metabolic pathways that were significantly different in e20 embryos from 32 wk 







Glycine, serine and threonine metabolism Glycine, Serine, 
Threonine 
0.00336 0.138 
Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, Threonine 
0.0109 0.205 
Methyl group metabolism Glycine, Serine 0.0296 0.205 
Glyoxylate and dicarboxylate metabolism Malate 0.0340 0.205 
Citrate cycle (TCA cycle) Malate, Succinate 0.0345 0.205 
Glutathione metabolism Glycine 0.0388 0.205 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
0.0401 0.205 
Propanoic acid metabolism Succinate 0.0472 0.215 
 
1 
Metabolic pathways that are different based on normalized e20 liver metabolites data in eggs 
from 32 wk vs 51 wk-old hen. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3











Figure 4.5 Principal component analysis (PCA) of liver metabolomic profile in eggs from 32 wk and 51 wk-old hens during 
development (Exp. 1). a. The PCA score plot showed a good separation in liver metabolites of embryos from 32 wk-old hens. b The 









Figure 4.6 Principal component analysis (PCA) of liver metabolomic profile in small and large eggs (45 wk) during development 
(Exp. 2). a. The PCA score plot showed a separation of e14 and e17 liver metabolites of embryos from small eggs, but not a clear 
cluster for e20 and posthatch day 1 samples. b The PCA score plot showed four groups separation in liver metabolites of embryos 






Figure 4.7 Hierarchical clustering analysis (HCA) for liver metabolites in embryos from 32 wk- 
old hens on e14, e17, e20 and posthatch day 1 (P1) (Exp. 1). The pattern of each parameter 
(shown in each column) was categorized by a Ward’s linkage hierarchical clustering method. 
The bars indicate the normalized metabolite fold change, with dark red boxes denoting a ratio 
greater than the mean and dark blue boxes denoting a ratio below the mean. The tree clusters and 
the shorter Euclidean distance indicate higher similarities. Similarity within two samples or two 





Figure 4.8 Hierarchical clustering analysis (HCA) for liver metabolites in embryos from 51 wk- 
old hens on e14, e17, e20 and posthatch day 1 (P1) (Exp. 1). The pattern of each parameter 
(shown in each column) was categorized by a Ward’s linkage hierarchical clustering method. 
The bars indicate the normalized metabolite fold change, with dark red boxes denoting a ratio 
greater than the mean and dark blue boxes denoting a ratio below the mean. The tree clusters and 
the shorter Euclidean distance indicate higher similarities. Similarity within two samples or two 






Figure 4.9 Hierarchical clustering analysis (HCA) for liver metabolites in embryos from small 
eggs from 45 wk- old hens on e14, e17, e20 and posthatch day 1 (P1) (Exp. 2). The pattern of 
each parameter (shown in each column) was categorized by a Ward’s linkage hierarchical 
clustering method. The bars indicate the normalized metabolite fold change, with dark red boxes 
denoting a ratio greater than the mean and dark blue boxes denoting a ratio below the mean. The 
tree clusters and the shorter Euclidean distance indicate higher similarities. Similarity within two 
samples or two metabolites is represented by branch height. The shorter the branch height, the 





Figure 4.10 Hierarchical clustering analysis (HCA) of liver metabolites in embryos from large 
eggs from 45 wk- old hens on e14, e17, e20 and posthatch day 1 (P1) (Exp. 2). The pattern of 
each parameter (shown in each column) was categorized by a Ward’s linkage hierarchical 
clustering method. The bars indicate the normalized metabolite fold change, with dark red boxes 
denoting a ratio greater than the mean and dark blue boxes denoting a ratio below the mean. The 
tree clusters and the shorter Euclidean distance indicate higher similarities. Similarity within two 
samples or two metabolites is represented by branch height. The shorter the branch height, the 




Table 4.6 Liver metabolic pathways that were significantly different during development of 







Starch and sucrose metabolism Glucose, Maltose < 0.0001 < 0.0001 







< 0.0001 < 0.0001 
Arachidonic acid metabolism Arachidonic acid < 0.0001 < 0.0001 
Amino sugar and nucleotide sugar metabolism Hexose < 0.0001 < 0.0001 
Galactose metabolism Glucose, Hexose, 
Melibiose, Glycerol 
< 0.0001 < 0.0001 
Fatty acid elongation Palmitic acid < 0.0001 < 0.0001 
Fatty acid metabolism Palmitic acid < 0.0001 < 0.0001 
Biosynthesis of unsaturated fatty acids Palmitic, Oleic, 
Stearic, Linoleic, 
Arachidonic acid 
< 0.0001 < 0.0001 
Glycolysis or Gluconeogenesis Glucose, Lactate < 0.0001 < 0.0001 
Arginine and proline metabolism Glutamine, 
Aspartate, Proline 
< 0.0001 < 0.0001 
Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, 
Threonine 
< 0.0001 < 0.0001 
Purine metabolism Glutamine < 0.0001 < 0.0001 
D-Glutamine and D-glutamate metabolism Glutamine < 0.0001 < 0.0001 
Methyl group metabolism Glycine, Serine < 0.0001 < 0.0001 
Glycine, serine and threonine metabolism Glycine, Serine, 
Threonine 
< 0.0001 < 0.0001 
Alanine, aspartate and glutamate metabolism Succinate, Aspartate, 
Aspargine, 
Glutamine 
< 0.0001 < 0.0001 
Fatty acid biosynthesis Palmitic, Oleic, 
Stearic acid 
< 0.0001 < 0.0001 
Cysteine and methionine metabolism Serine < 0.0001 < 0.0001 











Pathway Name Metabolite P value FDR 
Propanoate metabolism Succinate 0.000188 0.000329 
Linoleic acid metabolism Linoleic acid 0.000402 0.000675 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
0.00061 0.000985 
Pyrimidine metabolism Uridine 0.00133 0.00207 
Pantothenate and CoA biosynthesis Valine 0.00363 0.00544 
Steroid biosynthesis Cholesterol 0.00404 0.00548 
Primary bile acid biosynthesis Cholesterol 0.00404 0.00548 
Steroid hormone biosynthesis Cholesterol 0.00404 0.00548 
Histidine metabolism Aspartate 0.00554 0.00706 
beta-Alanine metabolism Aspartate 0.00554 0.00706 
Phenylalanine, tyrosine and tryptophan metabolism Phenylalanine 0.00668 0.00789 
Citrate cycle (TCA cycle) Malate, Succinate 0.00676 0.00789 
 
1 
Metabolic pathways that are different based on normalized liver metabolite data in eggs from 
32 wk-old hens on e14, e17, e20 and posthatch day 1. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3
















Table 4.7 Liver metabolic pathways that were significantly different during development of 














< 0.0001 < 0.0001 
Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, Threonine 
< 0.0001 < 0.0001 
Starch and sucrose metabolism Glucose, Maltose < 0.0001 < 0.0001 
Glycine, serine and threonine metabolism Glycine, Serine, 
Threonine 
< 0.0001 < 0.0001 
Alanine, aspartate and glutamate metabolism Succinate, Aspartate, 
Aspargine, Glutamine 
< 0.0001 < 0.0001 
Amino sugar and nucleotide sugar metabolism Hexose < 0.0001 < 0.0001 
Pyruvate metabolism Lactate, Malate < 0.0001 < 0.0001 
Glycolysis or Gluconeogenesis Glucose, Lactate < 0.0001 < 0.0001 
Methyl group metabolism Glycine, Serine < 0.0001 < 0.0001 
Biosynthesis of unsaturated fatty acids Palmitic, Oleic, Stearic, 
Linoleic, Arachidonic 
acid 
< 0.0001 < 0.0001 
Fatty acid elongation Palmitic acid < 0.0001 < 0.0001 
Fatty acid metabolism Palmitic acid < 0.0001 < 0.0001 
Galactose metabolism Glucose, Hexose, 
Melibiose, Glycerol 
< 0.0001 < 0.0001 
Purine metabolism Glutamine < 0.0001 < 0.0001 
D-Glutamine and D-glutamate metabolism Glutamine < 0.0001 < 0.0001 
Fatty acid biosynthesis Palmitic, Oleic, Stearic 
acid 
< 0.0001 < 0.0001 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
< 0.0001 < 0.0001 
Arginine and proline metabolism Glutamine, Aspartate, 
Proline 
< 0.0001 < 0.0001 
Citrate cycle (TCA cycle) 
Sphingolipid metabolism 












Pathway Name Metabolites P value FDR 
Lysine degradation Lysine 0.000118 0.000206 
Biotin metabolism Lysine 0.000118 0.000206 
Propanoic acid metabolism Succinate 0.000189 0.000318 
Synthesis and degradation of ketones β-hydroxybutyric acid 0.000766 0.00124 
Linoleic acid metabolism Linoleic acid 0.00146 0.00228 
Arachidonic acid metabolism Arachidonic acid 0.00188 0.00282 
Glutathione metabolism Glycine 0.00218 0.00305 
Histidine metabolism Aspartate 0.00355 0.00466 
beta-Alanine metabolism Aspartate 0.00355 0.00466 
Pantothenate and CoA biosynthesis Valine 0.0132 0.0169 
Glyoxylate and dicarboxylate metabolism Malate 0.0243 0.0301 
Glycerolipid metabolism Glycerol 0.0337 0.0404 
 
1 
Metabolic pathways that are different based on normalized liver metabolite data in embryos 
from 51 wk-old hens on e14, e17, e20 and posthatch day 1. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3














Table 4.8 Liver metabolic pathways that were significantly different during development of 







Galactose metabolism Glucose, Hexose, 
Melibiose, Glycerol 
< 0.0001 < 0.0001 
Biosynthesis of unsaturated fatty acids Palmitic, Oleic, Stearic, 
Linoleic, Arachidonic 
acid 
< 0.0001 < 0.0001 
Fatty acid biosynthesis Palmitic, Oleic, Stearic 
acid 
< 0.0001 < 0.0001 
Alanine, aspartate and glutamate metabolism Succinate, Aspartate, 
Aspargine, Glutamine 
0.000165 0.001691 
Linoleic acid metabolism Linoleic acid 0.000453 0.003708 
Fatty acid elongation Palmitic acid 0.000633 0.003708 
Fatty acid metabolism Palmitic acid 0.000633 0.003708 
Arginine and proline metabolism Glutamine, Aspartate, 
Proline 
0.00144 0.00672 
Pyruvate metabolism Lactate, Malate 0.00148 0.00672 
Fructose and mannose metabolism Glucitol 0.00218 0.00893 








Histidine metabolism Aspartate 0.00283 0.00893 
beta-Alanine metabolism Aspartate 0.00283 0.00893 
Lysine degradation Lysine 0.00396 0.01083 
Biotin metabolism Lysine 0.00396 0.01083 
Valine, leucine and isoleucine Metabolism Valine, Leucine, 
Isoleucine, Threonine 
0.0186 0.0478 
Starch and sucrose metabolism Glucose, Maltose 0.0242 0.0584 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
0.0264 0.0602 
Synthesis and degradation of ketone bodies β-hydroxybutyric acid 0.0384 0.0788 
Amino sugar and nucleotide sugar 
metabolism 





Metabolic pathways that are different based on normalized liver metabolites data in small eggs 
on e14, e17, e20 and posthatch day 1. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3

























Table 4.9 Liver metabolic pathways that were significantly different during development of 














< 0.0001 < 0.0001 
Fatty acid biosynthesis Palmitic, Oleic, Stearic 
acid 
< 0.0001 0.000142 
Biosynthesis of unsaturated fatty acids Palmitic, Oleic, Stearic, 
Linoleic, Arachidonic 
acid 
< 0.0001 0.000142 




< 0.0001 0.000151 
Arginine and proline metabolism Glutamine, Aspartate, 
Proline 
< 0.0001 0.000223 
Starch and sucrose metabolism Glucose, Maltose < 0.0001 0.000409 
Galactose metabolism Glucose, Hexose, 
Melibiose, Glycerol 
0.000155 0.000703 
Phenylalanine, tyrosine and tryptophan 
metabolism 
Phenylalanine 0.000176 0.000703 
Lysine degradation Lysine 0.000215 0.000703 
Biotin metabolism Lysine 0.000215 0.000703 
Histidine metabolism Aspartate 0.000226 0.000703 
beta-Alanine metabolism Aspartate 0.000226 0.000703 
Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, Threonine 
0.000240 0.000703 
Fatty acid elongation Palmitic acid 0.000996 0.00240 
Fatty acid metabolism Palmitic acid 0.000996 0.00240 
Pantothenate and CoA biosynthesis Valine 0.00357 0.00762 





Glycolysis or Gluconeogenesis 
Steroid biosynthesis 












Pathway Name Metabolites P value FDR 
Purine metabolism 
D-Glutamine and D-glutamate metabolism 











Methyl group metabolism Glycine, Serine 0.0125 0.0177 
Propanoate metabolism Succinate 0.0190 0.0260 
Glycerolipid metabolism Glycerol 0.0199 0.0263 
Butyric acid metabolism Succinate, β-
hydroxybutyric acid 
0.0212 0.0271 
Pyrimidine metabolism Uridine 0.0334 0.0415 
Synthesis and degradation of ketones β-hydroxybutyric acid 0.0469 0.0566 
 
1 
Metabolic pathways that are different based on normalized liver metabolites data in large eggs 
on e14, e17, e20 and posthatch day 1. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3












Figure 4.11 Principal component analysis (PCA) of e14 blood metabolomic profile. a The PCA score plot distinguishes the metabolic 
profiles of blood metabolites in eggs from 32 wk (Δ) vs 51 wk (+) old hens on e14 (Exp. 1). The first three characters represent the 
embryo developmental age (e14) followed by age (32 wk, 51 wk) and replicates (1-5 samples). b Loading plot shows the correlations 
among individual blood metabolite of PC1 and PC2 (eigenvalues). Variables (metabolite) with the same distance from zero with 






Table 4.10 Metabolic pathways based on blood metabolites that were significantly different in 







Valine, leucine and isoleucine metabolism Valine, Leucine, 
Isoleucine, Threonine 
0.000369 0.00603 
Linoleic acid metabolism Linoleic acid 0.000389 0.00603 












Fatty acid biosynthesis Palmitic, Oleic, Stearic 
acid 
0.00940 0.0583 
Pantothenate and CoA biosynthesis Valine 0.0177 0.0725 
Alanine, aspartate and glutamate metabolism Succinate, Aspartate, 
Aspargine, Glutamine 
0.0189 0.0725 
Cysteine and methionine metabolism Serine 0.0210 0.0725 
Glycerolipid metabolism Glycerol 0.0349 0.0982 
Fatty acid elongation Palmitic acid 0.0380 0.0982 
Fatty acid metabolism Palmitic acid 0.0380 0.0982 





Metabolic pathways that are different based on normalized e14 blood metabolites data in eggs 
from 32 wk vs 51 wk old hens. 
2
 Metabolites that were involved in the listed metabolic pathways are shown.  
3










In Chapter 3, the energy-sensing mechanism in embryos from small compared to large 
eggs was investigated. Although AMPK activity was observed to be higher in the liver of large 
egg embryos and egg nutrient supply was greater for the embryos from large eggs, it was not 
clear what egg and embryo factors lead to these differences. In that study, small eggs were from 
young hens (26 wk) whereas large eggs were laid by older hens (42 wk). Thus, hen age may have 
confounded the effects due to egg size and possibly egg composition. Therefore, in this study, we 
investigated the influences of hen age and egg size separately on chicken embryo growth and 
development by exploring embryo metabolism during later development (e14-posthatch day 1). 
The initial yolk to albumen ratio was higher in eggs of the same weight but from different 
ages of hens (32 wk vs 51 wk). Thus, embryos from 51 wk-old hens had a more energy-dense 
nutrient supply. However, we did not observe any embryo or liver weight difference from e11 to 
posthatch day 1 in this group of eggs, which was not in agreement with the study by Shanawany 
(1984). In that study, e18 embryo weights were reported to be greater in eggs from older hens 
than younger hens given the same egg weight category. The reason for this inconsistency is 
unclear. One possibility is that the sample size was not large enough in the current study to detect 
embryo weight difference. The weights of yolk and albumen were lower in small eggs than in 
large eggs, and the initial yolk to albumen ratio tended to be higher in small compared to large 
eggs, although this ratio differed by 0.3 units (the same as in Exp. 1). We noticed that the 
insignificance may be attributed to one sample that introduced large variation after further 
evaluating the original data. If the data from this sample were taken out, the ratio was significant 
between small versus large eggs, and consistent with the literature. Thus, we believe that yolk to 
albumen ratio was greater in the small eggs relative to large eggs in the current study, which is 
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consistent with an earlier study where small eggs had a higher proportion of yolk than large eggs 
from the same clutch (Vieira and Moran, 1998). The embryo, hatchling and liver weights 
differed on e20 and posthatch day 1, which we anticipated because nutrient supply was greater 
for embryos from large eggs.  
As the yolk to albumen ratio was greater in eggs from 51 wk-old hens, and yolk contains 
45% lipid (DM basis, Sato et al., 2006) that provides important fatty acids necessary for embryo 
development, we measured fatty acid composition in the yolk at set (e0) and on e11, e14, e17, 
e20 and posthatch day 1 to determine rates and patterns of fatty acid utilization during 
development. The proportions of oleic and linolenic acids were higher in eggs from 51 wk-old 
hens at each developmental age whereas palmitic and palmitoleic acids accounted for a higher 
proportion of fatty acids in yolks from 32 wk-old hens. The latter has also been observed by 
Latour et al. (1998). However, these fatty acids proportions were not different in yolk from eggs 
of different sizes from 45 wk-old hens. This may indicate that the yolk fatty acid profile is 
influenced by hen age but not egg size. 
From the above results, it appears that hen age affects the yolk to albumen ratio whereas 
egg size determines egg nutrient content. Although there are studies reporting the effects of both 
hen age and egg size on hatchling quality and broiler performance (Shanawany, 1984; Applegate 
and Lilburn, 1999a, b; Ulmer-Franco et al., 2010), none of these studies reported quantitative 
information about egg nutrient utilization and the metabolic pathways that resulted in the growth 
difference. Therefore, it prompted us to investigate whether hen age and egg size would 
influence embryo metabolism and substrate utilization during later development. A GC-MS- 
based metabolomics profiling approach was applied to systematically evaluate whether hen age 
and egg size alter embryo metabolism. We chose the embryo liver and blood to measure 
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metabolite differences because the liver is the central and most metabolically active organ in the 
developing embryo while blood reflects ongoing metabolic pathway activities in the entire 
embryo.  
To our knowledge, this is the first study that has employed a metabolomics profiling 
approach to investigate embryo metabolism. Our results clearly showed that e14 and e20 embryo 
liver metabolism differed in eggs from 32 wk vs 51 wk-old hens. The two metabolite clusters 
featured higher concentrations of palmitic, stearic and linoleic acids, BCAA, phenylalanine, 
glutamine, β-hydroxybutyric acid, glycerol and lactate but lower concentrations of succinate, 
glycine, threonine and oleic acid in e14 embryo livers from 32 wk compared to 51 wk-old hens. 
Similarly, the e14 blood metabolite profile of embryos from 32 wk-old hens reflected higher 
concentrations of BCAA, phenylalanine, glutamine and lactate as well as lower levels of glycine. 
The e20 liver had similar patterns of metabolites when compared to e14 embryos. Fatty acids are 
known to affect lipid utilization. For instance, oleic acid has a greater stimulatory effect on very 
low density lipoprotein (VLDL) secretion than palmitic acid in chicken liver cells (Mooney and 
Lane, 1981). VLDL is released into the circulation in ovo from the yolk sac membrane (Latour et 
al., 1998). The higher concentrations of oleic acid in embryo livers from 51 wk-old hens 
suggested that these embryos utilized yolk lipid to a greater extent compared to the embryos 
from 32 wk-old hens. 
BCAA are essential nutrients that are required specifically for protein synthesis (Harper 
et al., 1984), and especially leucine act as a regulator for protein synthesis (Escobar et al., 2006). 
However, a recent study in human obesity patients showed elevated BCAA may result in 
incomplete oxidation of fatty acids, and excess carbon from BCAA catabolism may contribute to 
higher rates of lipogenesis and gluconeogenesis (Newgard, 2012).  The present results showed a 
99 
 
difference in terms of BCAA metabolism in both e14 and e20 embryo livers from different ages 
of hens. Higher BCAA concentration in the liver may suggest a greater demand for protein 
synthesis in the embryos from 32 wk-old hens. Higher liver β-hydroxybutyric acid indicated the 
lower liver glycogen supply in embryos from 32 wk-old hens which may trigger the utilization of 
fatty acids for supply of energy. Hamidu et al., (2007) showed less O2 consumption by 
developing embryos from young hens (29 wk) compared to older hens (55 wk), which indicates a 
shift from fatty acid oxidation to oxidation of amino acids, glycerol and glucose. Indeed, liver 
lactate was higher in embryos from 32 wk-old hens, which would be expected under conditions 
of reduced oxygen permeability of the eggshell membrane leading to greater glucose metabolism 
to lactate (anaerobic metabolism). 
It is noteworthy that concentrations of glycine and threonine were higher in embryos 
from 51 wk-old hens. Glycine, threonine and serine metabolism was also found to be different in 
the pathway analysis for both e14 and e20 embryos. Glycine, sarcosine, serine and threonine and 
related metabolic pathways have been identified as pivotal substrates and pathways for cellular 
transformation (Locasale et al., 2011; Possemato et al., 2011) and murine embryonic stem cell 
proliferation (Wang et al., 2009).  Higher glycine, threonine and serine metabolism in embryos 
from 51 wk-old hens may have facilitated embryo development.  And, we did observe an embryo 
weight difference in the small compared to large eggs. We did not, however, observe differences 
in embryo metabolism between the two egg sizes by multivariate analysis on liver and blood 
metabolite data.  
PCA and HCA were performed to investigate developmental changes in embryo 
metabolism. Our results clearly showed that the four developmental ages could be easily 
distinguished on the basis of liver metabolites for embryos from 32 wk and 51 wk-old hens and 
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from the two sizes of eggs. Chicken embryos on e14, e17 and e20 fell into one large sub-tree 
regardless of whether they were from 32 wk or 51 wk-old hens, and this sub-tree clustered apart 
from posthatch day 1 chicks. This implies that metabolism in posthatch day 1chicks has changed 
dramatically in 1 to 2 days compared to the developing embryos. Pathway analysis displayed 
similar metabolic shifts in embryos from 32 wk and 51 wk-old hens that contributed to 
differences observed between developmental ages. However, pathways involving synthesis and 
degradation of ketones, glycerolipid and glutathione metabolism were unique to embryos from 
51 wk-old hens. This also reflected the fact that the proportion of yolk in eggs from older hens is 
higher, and hence reactions related to lipid metabolism would be more active.  
In summary, GC-MS based metabolmoics and multivariate analysis were used to provide 
information on liver and blood metabolites in embryos from two ages of breeders and from two 
sizes of eggs. With increasing hen age, the proportion of yolk poly-unsaturated fatty acids, in 
particular oleic acid and the essential fatty acid linolenic acid were higher. Metabolism was 
different in e14 and e20 embryos from different ages of breeders. The PCA and HCA of liver 
data showed four distinct clusters of metabolites that corresponded to the four distinct 
developmental ages.  Liver metabolite fold changes corresponding to e14, e17 and e20 were 
similar and mapped closely together, while the cluster of posthatch day1chicks clustered 
separately. Thus, maternal age influences embryo metabolism, and certain pathways of interest 
(i.e., BCAA metabolism, glycine, serine and threonine metabolism) could be further interrogated 
to establish the functions of these pathways in embryo development and growth. This study also 
demonstrated the potential of GC-MS based metabolomics as a tool to characterize metabolic 
pathways and to discover potential biomarkers of embryo development that correlate with 
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We aimed to investigate gluconeogenesis and substrate partitioning in the Krebs cycle, 
and related metabolic pathways, in embryonic (e) day e14 and e19 chicken embryos.  This was 
accomplished by employing a constant tracer infusion approach in ovo. The hypotheses were that 
glucose and non-essential amino acid (NEAA) synthesis would increase from e14 to e19 
embryos. A syringe pump was used to continuously infuse [U-
13
C] glucose or [U-
13
C] glycerol 
for 8 h into the chorio-allantoic compartment of eggs on e14 and e19 to attain a high level of 
incorporation of 
13
C into metabolites of intermediary metabolism. Based on [U-
13
C] glucose 
infusion, the glucose entry rate, Cori cycling and gluconeogenesis (non-Cori cycle flux) were 
higher (P < 0.05) in e19 compared to e14 embryos, presumably to support glycogen deposition 
in liver and muscle. Consistent with this finding, the contribution of glucose to alanine, aspartate, 
and glutamate synthesis was greater (P < 0.05) in e14 than in e19 embryos. Although the 
contribution of glycerol to gluconeogenesis by e19 embryos was greater (P < 0.05) than in e14 
embryos, overall, glycerol made a small contribution (1.3-6.0%) to glucose synthesis. NEAA 
synthesis derived from glycerol was higher (P < 0.05) in e19 compared to e14 embryos. Based 
on infusion of [U-
13
C] glucose, the activity of pyruvate carboxylase (PC) versus pyruvate 
dehydrogenase (PDH) was relatively higher (P < 0.05) in e14 compared to e19 embryos, 
indicating increased anaplerotic flux into the Krebs cycle for NEAA synthesis by e14 embryos. 
In conclusion, the constant tracer infusion approach developed in this study allowed for the 
measurement of embryo metabolism during a shorter window of developing embryos compared 
to the previous approach of dosing tracer for 3 to 4 days. Lastly, this study provided quantititave 
information on the developmental (e14 and e19) shifts in gluconeogenesis, lipolysis and NEAA 
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synthesis, as well as qualitative estimates of the activity of enzymes central to glucose and fatty 









Metabolism in the chicken embryo during later development (e1-posthatch day 1) 
undergoes dramatic changes to adjust to the different physiological and metabolic needs for 
growth. As the embryo develops and O2 diffusion across the air-cell membrane increases, the 
substrates that the embryo metabolizes for energy must shift from carbohydrates (respiratory 
quotient 1.0) to fatty acids (respiratory quotient 0.7) (Rahn et al., 1974; Moran, 2007; De 
Olivera et al., 2008). Although the egg nutrient composition features 45% lipids, 47% protein 
and less than 3% carbohydrates on a dry matter basis (Romanoff and Romanoff, 1967), glucose 
is an essential nutrient not only for energy supply, but also for brain and immune system 
development (Humphrey and Rudrappa, 2008). Plasma glucose was detected as early as 
embryonic (e) day e4 and increased steadily throughout development (Hazelwood, 1971; Savon 
et al., 1993). High rates of gluconeogenesis and glycogenesis occur after e13 (Pearce, 1977; 
Picardo and Dickson, 1982). The upregulation of gluconeogenesis is crucial in the later term 
developing chicken embryo to ensure blood glucose supply for development, and for muscle and 
liver glycogen storage for pipping and hatching. 
In this study, quantifications of gluconeogenesis and substrate partition were particularly 
of interest as well as the composition of substrates utilized in the Krebs cycle and related 
metabolic pathways in e14 and e19 embryos. Based on the earlier studies (Chapters 3 and 4), e14 
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is a critical time point in embryo development. At this stage, liver AMPK activity is at its 
highest, and embryo metabolism differs on e14 when comparing eggs from young vs old hens. 
From e14 onwards to e19, the rate of embryo development and growth (2.5-fold increase in 
weight) is most dramatic with enhanced oxygen consumption, hormonal changes and storage of 
glycogen for pipping and emergence. Because this is a critical and dynamic period of embryo 
development, the rate of gluconeogenesis and substrate partition through the Krebs cycle must be 
finely balanced. It also represents the period when egg nutrient composition will be most 
influential to embryo growth, physiology and survival. 
[U-
13
C] glucose has been used as a tracer to investigate the regulation of glucose 
metabolism in human infants and adults, piglets, sheep and in developing chicken embryos in the 
laboratory (Sunny and Bequette, 2010). There are several advantages of using uniformly 
13
C-
labeled glucose and mass isotopomer distribution analysis (MIDA) rather than radio-isotopes. 
First, the enrichment of [M+6] glucose, i.e. the infused [U-
13
C] glucose, reflects the rate of 
glucose entry rate resulting from glucose absorption, glucose carbon recycling and 
gluconeogenesis from non-glucose sources (i.e., amino acids and glycerol) (Pascual et al., 1997). 
Employing MIDA, 
13
C recycling, Cori cycling and gluconeogenesis can be quantified from the 
appearance of glucose with less than six carbons labeled. Second, when 
13
C-skeletons from 
glucose enter intermediary metabolism, the labeling patterns in intermediates and products 
downstream of glucose catabolism reflect the activity of the pathways the carbon skeletons 
traversed and as well as unequivocal evidence that these end-products are synthesized in the cell, 
tissue or whole body (Berthold et al., 1994; Pascual et al., 1997; Wykes et al., 1998). In 
relationship to the developing chicken embryo, Sunny and Bequette, (2010) have previously 
demonstrated that the embryo is capable of synthesizing so-called non-essential amino acids 
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(NEAA), which raises the question “What are the substrates that are metabolized for NEAA 
synthesis?” 
Glycerol is a well-known glucogenic substrate. In the liver, glycerol is phosphorylated 
and subsequently converted to glyceraldehyde phosphate and dihydroxyacetone phosphate. Thus, 
glycerol enters the Krebs cycle, gluconeogenesis, or pentose phosphate pathway through the 3- 
carbon pool. [U-
13
C] Glycerol has been used to quantify the contribution of glycerol to glucose 
synthesis in healthy term and preterm infants (Patel and Kalhan, 1992; Sunehag et al., 1999). 
And, the turnover of 
13
C of glycerol reflects the rate of lypolysis as well as the contribution of 
glycerol to the syntheses of other intermediates. A diagram showing [U-
13
C] glucose and [U-
13
C] 
glycerol metabolism and stable isotope distribution in the intermediates and final products is 
presented in Figure 5.1.  
Previously, a daily injection protocol was employed for dosing stable isotope tracers into 
the chorio-allantoic compartment of eggs in the laboratory (Sunny and Bequette, 2010, 2011). 
Though steady state labeling was often achieved, the method was time-consuming (3-4 days of 
dosing), embryo losses were common, and there were such large variations in the enrichment of 
the dosed tracer in the blood that necessitated elimination of observations. Moreover, the 
contribution of glycerol to glucose synthesis was not determined due to the large variations in 
blood glycerol enrichment. Therefore, to overcome the variation and shorten the period of tracer 
administration so that smaller windows in embryo development could be investigated, a constant 
tracer infusion protocol was developed (8-h infusion) in the current study to improve steady state 
labeling of intermediates and improve the accuracy of estimating gluconeogenesis, glycerol 
turnover and substrate utilization by e14 and e19 chicken embryos. 
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Materials and Methods 
Egg Incubation and Stable Isotope Tracer Infusion  
The experimental protocol was approved by the University of Maryland Institutional 
Animal Care and Use Committee. 
Fertile eggs from layers (~50 wk-old, White leghorn) (61.2 ± 3.2 g, n = 51) were acquired 
from B & E eggs (York Springs, PA). Eggs were incubated under the standard condition of 65% 
relative humidity and 37.5°C. On embryonic (e) day 9, eggs were candled and undeveloped eggs 





C] glycerol (Exp. 2) (99 atom percent 
13
C, Cambridge Isotope Laboratories, Inc., 
Andover, MA) into chorio-allantoic fluid. Mass spectrometry analysis confirmed isotopomer 
purity of 93.7% 
13




C] glucose tracer, and isotopomer purity of 96.6% 
13





On e14 and e19, the air cell end of the egg was sterilized with 70% ethanol before 
piercing of the egg shell. A 27-gauge blunted needle was introduced 2-3 mm through the air-cell 
membrane into the chorio-allantoic compartment and glued in place to the egg shell. The needle 
was then connected to a 1m polyethylene infusion line (I.D. 0.38mm; O.D. 1.09mm, Becton 
Dickinson and Co., Sparks, MD) with a 0.5mL syringe attached. [U-
13
C] Glucose (0.15 g/g 
saline) or [U-
13
C] glycerol (0.14 g/g saline) was continuously (8 h) infused into the eggs using a 
speed adjustable syringe pump (NE-300, New Era Pump Systems, Inc., Farmingdale, NY) 
(Figure 5.2). The pump speed was set at 47.49 µL/h for [U-
13
C] glucose and 50 µL/h for [U-
13
C] 
glycerol to deliver a total of 50 mg [U-
13
C] glucose or [U-
13
C] glycerol over the 8-h infusion 
period. The initial and final weights of the tracer infusion syringe and time of infusion were 









C] Glucose and [U-
13
C] glycerol metabolism and stable isotope distribution in 








Sample Collection and Analysis 
At the end of infusion, eggs were dissected for collection of blood and liver. After 
removing the infusion line, a hole was made into the large end of the egg with scissors, the 
crown removed, and whole egg contents were carefully transferred to a petri-dish on ice. The 
vitelline vessels (artery and vein) were exposed on the top and clearly visible. Blood was drawn 
using a 0.5mL syringe equipped with a 27-gauge needle (Becton Dickinson and Co.) piercing 
into the blood vessels. The blood was transferred into a 1 mL blood collection tube (Multivette
®
, 
Sarstedt AG & Co) with a solid lithium heparin ring to prevent blood clotting and immediately 
frozen at -20 
◦
C.  The weights of embryos were recorded, and the whole liver was immediately 
wrapped in aluminum foil before being stored at -20 
◦
C for later analysis.  
Glucose Enrichments 
For determination of blood glucose enrichments, samples (50 µL) were extracted with 0.5 
mL of ice-cold methanol, vortex mixed and centrifuged for 10 min at 13,000 × g at room 
temperature. The supernatant was transferred to a 2mL v-vial and reduced to dryness under N2 
gas at room temperature. The di-O-isopropylidene acetate (IPAc) derivative of glucose was 
formed prior to GC-MS analysis. The derivative was separated by GC using a fused silica 
capillary column (ZB-50; 30 m × 0.25 mm× 0.50 µm, Phenomenex, Torrance, CA) with helium 
as the carrier gas. For liver free glucose enrichment, 1 mL of ice-cold 10% sulpho-salicylic acid 
(w/v) was added to samples (60 mg) and homogenized on ice. The homogenates were 
centrifuged for 10 min at 13, 000 ×g at room temperature. The supernatant was applied to cation-
exchange resin (AG 50W-X8 resin, 100-200 mesh; Bio-Rad Laboratories, Hercules, CA), and 
glucose was eluted from the resin with 2 mL of distilled H2O and frozen prior to being 
lyophilized to dryness. The IPAc derivative of glucose was formed as above. Ions with mass-to-
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charge (m/z) 287-293 were monitored using selective ion monitoring (SIM) with the MS 
operated in electron ionization mode (Hannestad and Lundblad, 1997). 
Blood Lactate and Alanine Enrichments  
Lactate and alanine in the blood were extracted using ice-cold methanol. Briefly, 0.5 mL 
of ice-cold methanol was added to 50 µL of blood, vortexed briefly and then samples were 
centrifuged at 13,000 ×g for 10 min at room temperature. The supernatant was reduced to 
dryness under N2 gas. The tert-butyl dimethylsilyl (t-BDMS) derivatives were separated by GC 
on a fused silica capillary column (ZB-50; 30m × 0.25mm × 0.50µm) with helium as the carrier 
gas. Selective ion monitoring of ions with m/z 261-264 for lactate and m/z 260-263 for alanine 
was performed with the MS operated under electron ionization mode.  
Glycerol Enrichments 
Blood glycerol (50 µL) was extracted with 0.5 mL of ice-cold methanol, vigorously 
vortexed and centrifuged at 13,000 ×g for 10 min. The supernatant was transferred to a 1-mL v-
vial and reduced to dryness under N2 gas. A mixture of acetic anhydride: pyridine (v/v, 2:1) was 
added to the dried sample and heated at 60
◦
C for 30 min. The sample was reduced to dryness 
under N2 gas and reconstituted in ethyl acetate (100 µL) before GC-MS analysis. The glycerol 
triacetate derivative was separated by GC using a fused silica capillary column (HP-5; 30m × 
0.25mm ×0.25µm, Hewlett-Packard, Palo Alto, CA) with helium as the carrier gas. The MS was 
operated in methane positive chemical ionization mode, and ions of m/z 159-163 were monitored 
for glycerol enrichment (Kalhan et al., 2001).  
Amino Acid Enrichments  
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For determination of NEAA enrichment, liver samples (60 mg) were deproteinized by the 
addition of ice-cold 10% sulpho-salicylic acid (w/v) and homogenized on ice. The homogenates 
were centrifuged for 10 min at 13, 000 ×g at room temperature, and the acid supernatant applied 
to cation-exchange (AG 50W-X8 resin, 100-200 mesh; Bio-Rad Laboratories). Amino acids 
were eluted from resin with 2 mL of 2M NH4OH followed by 1 mL of H2O. The eluate was 
frozen and lyophilized to dryness. Amino acids were derivatized with a mixture of N-methyl-N-
[tert-butyldimethyl-silyl] trifluoroacetimide (MTBSTFA) containing 1% tert-
butyldimethylchlorosilane (TBDMCS) and dimethylformamide (DMF) (v/v, 1:1). After heating 
by microwave (200 watts for 2 min), the amino acid t-BDMS derivatives were separated by GC 
with a fused silica capillary column (ZB-50; 30 m × 0.25 mm × 0.50 µm, Phenomenex) and the 
MS operated in electron ionization mode. The following ions of m/z were monitored: lactate 
261-264, alanine 260-263, glycine 246-248, proline 286-290, serine 390-393, aspartate 418-422,  
glutamate 330-334, and glutamine 431-436. The fragment ions monitored (e.g., 261 for alanine) 
contained all of the carbons for that amino acid.     
Calculations 
Throughout this chapter, isotopomers of glucose, glycerol and their metabolites 
containing 1, 2, 3,…n 
13
C atoms were denoted as [M+1], [M+2], [M+3], … [M+n].  The crude 






N) present in the molecule and in the derivative employing a matrix approach (Fernandez et al., 
1996). Natural isotopomer distributions in unlabelled glucose, glycerol, lactate and amino acids 
were quantified using unlabelled pure standards. Corrected enrichments of precursors, 
intermediates and products are reported as moles of tracer [M+n] per 100 moles of tracee [M+0] 
for all calculations.  
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Calculation of glucose entry rate, recycling (Cori cycle) and gluconeogenesis were based 
on the dilution of [M+6] glucose (Katz et al., 1989) and 
13
C isotopomer recycling derived from 
glycolytic metabolism of [U-
13
C  (Tayek et al., 1996, 1997). The assumption of the calculation of 
gluconeogenesis is that glucose synthesis via pyruvate results in 
13
C recycling to glucose (Wykes 
et al., 1998). The calculation in this chapter was also based on the assumption that the labeling of 
alanine, aspartate and glutamate is a direct reflection of the labeling of their respective 
transamination partners pyruvate, oxaloacetate and α-ketoglutarate when [U-
13
C] glucose or [U-
13
C] glycerol was infused (Berthold et al., 1994). 
Apparent glucose entry rate was calculated according to Wykes et al. (1998):  
             [U-
13
C] glucose infused (mg/h) × (
 
             
  1)                                            (1) 
where P is the isotopic purity of [U-
13
C] glucose tracer (93.7%).  
Glucose carbon 
13
C recycling was calculated according to Pascual et al. (1997): 
              
             
             
                                                                                               (2) 
where 
                                                                       (3) 
                                         .                                               (4) 
Cori cycling, as a fraction of glucose entry rate, was based on [U-
13




            
                 
                       
                                                                                 (5) 
Equation (5) calculates the fraction of labeled glucose molecules that result from carbon 
recycling without consideration of the dilution of unlabeled molecules arisen from the entry of 
amino acid and fatty acid carbons into the 3-carbon and Krebs cycle intermediate pools (Tayek 
and Katz, 1996). Metabolism of [M+6] glucose and glucose carbon recycling leads to the 
production of [M+6] and [M+3] glucose isotopomers. Hence, [M+3] pyruvate can only be 
synthesized from these two glucose isotopomers. [M+3] pyruvate yields [M+3] alanine via 
transamination, whereas metabolism of [M+3] pyruvate in the Krebs cycle leads to the synthesis 
of [M+3] oxaloacetate and, thus, [M+3] aspartate via transamination (Pascual et al., 1998). The 
fractional contribution of glucose to alanine or aspartate fluxes was calculated as: 
              
                              
                               
                                                              (6) 
Furthermore, metabolism of [M+3] pyruvate introduces [M+3] oxaloacetate via pyruvate 
carboxylase (PC) into the Krebs cycle. Alternatively, decarboxylation of [M+3] pyruvate via 
pyruvate dehydrogenase (PDH) leads to the synthesis of [M+2] acetyl-CoA. Subsequently, 
concurrent metabolism of [M+3] pyruvate via PC and PDH activity leads to the synthesis of 
[M+2] and [M+3] α-ketoglutarate isotopomers and via transamination [M+2] and [M+3] 
glutamate isotopomers (Pascual et al., 1998). The contribution of glucose to glutamate synthesis 
via oxalacetate is calculated as: 
               
                
                              
                                                    (7) 
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and the contribution of 3-carbon pool precursors to glutamate synthesis is calculated as:                  
               
                
            
                                                                                                   (8) 
Here, [M+3] glutamate was multiplied by a factor of 2 because of fumarate-oxaloacetate cycling 
which leads to an equilibrium mixture of two isomers of [M+3] oxaloacetate. One isomer will be 
labeled in carbons 1-3 while the other isomer is labeled in carbons 2-4. When citrate is 
metabolized to α-ketoglutarate, carbon 1 of citrate that arises from oxaloacetate is lost. 
Therefore, only [M+3] oxaloacetate labeled in carbons 2-4 can lead to the synthesis of [M+3] 
glutamate. If [M+3] glutamate enrichment was used in the equation (8) without multiplying by 
the factor of 2, the true contribution of [M+3] oxaloacetate would be underestimated by 100% 
(Pascual et al., 1998). Pyruvate carboxylase and pyruvate dehydrogenase activities can also be 
estimated by: 
                  
              
             
                                                                             (9) 
             
               
             
                                                                         (10) 
In Equation (10), [M+2] acetyl-CoA enrichment was calculated as: 
[M+2] glutamate   (1   
              
              
                                       (11) 
And, the measurement of PC versus PDH activity was calculated from the ratio: 
                  
              
               
                                                                                               (12) 
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The basis of this calculation is that [M+2] fumarate with 
13
C at carbons 3 and 4 will be produced 
when [M+3] oxaloacetate is metabolized during the first turn in the Krebs cycle, regardless of the 
position of 
13
C in the oxaloacetate. Hence, the enrichment of [M+2] oxaloacetate should be equal 
to [M+3] oxaloacetate after the first turn in the Krebs cycle. The enrichment of [M+2] glutamate 
synthesized from [M+2] oxaloacetate will be the same as the enrichment of [M+3] oxaloacetate 
after the second turn if we do not consider the entry of other sources of 
13
C. In fact, of the final 
enrichment of [M+2] glutamate, part of it will be generated in the Krebs cycle on the first turn 
metabolism of [M+3] oxaloacetate with 
13
C at carbons 1-3. A portion of the [M+2] glutamate 
enrichment is ascribed to the metabolism of [M+2] oxaloacetate in the second turn of the Krebs 
cycle. The differences between [M+2] glutamate and these two parts of [M+2] glutamate 
enrichment should be contributed by the entry of [M+2] acetyl-CoA from [M+3] pyruvate 
(Berthold et al., 1994). Thus, the contribution of the 3-carbon pool to [M+2] acetyl-CoA 
synthesis is calculated as: 
             
               
                            
                                                           (13) 
When [U-
13
C] glycerol was infused into embryos, glycerol entry rate was calculated as:  
               [U-
13
C] glycerol infused (mg/h) × (
 
 
  1)                                                              (14) 
Where P is the isotopic purity (96.6%) of the [U-
13
C] glycerol tracer, and where G is: 
               
             
                            
                                                        (15) 
The fractional contributon of glycerol to gluconeogenesis was estimated as: 
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                                                                             (16) 
The contributions of glycerol to the syntheses of alanine, aspartate and glutamate were calculated 
as:  
                 
                               
             
                                                   (17) 
                 
                
             
                                                                      (18) 
As stated above, [M+3] glutamate enrichment was multiplied by 2 due to oxaloacetate and 
fumarate cycling and equilibrium.  
Statistical Analysis 
All data were verified to meet assumptions of normality and homogeneity of variance. 
Results were analyzed by Student’s t-test procedure of SAS 9.2 (SAS Institute Inc., Cary, NC). 





The initial egg weights were not different between e14 and e19 embryos in the 
experiments where [U-
13
C] glucose (Exp. 1) or [U-
13
C] glycerol (Exp. 2) were infused (Table 
5.2 and Table 5.3). The weights of embryos on e14 differed (P < 0.0001) from those of e19 
embryos in both experiments. Overall, embryo weight increased by 210 to 250% between e14 











C recycling of glucose (%) and glucose molecule recycling (%) in blood and 
liver glucose in the e14 and e19 chicken embryos were as shown in Table 5.1. The tracer:tracee 
ratios of blood [M+3] and [M+6] glucose were substantially higher (P < 0.05) in e14 than those 
of e19 embryos. Likewise, the tracer:tracee ratios of liver [M+3] and [M+6] glucose were higher 
(P < 0.01) in e14 versus e19 embryos. The lower enrichments in e19 embryos reflect greater 
dilution of glucose as a result of higher rates of glucose entry. Irrespective of glucose pool, 
glucose 
13
C recycling and glucose molecule recycling did not change with the day of 
development. Values for apparent glucose entry rate, Cori cycling and gluconeogenesis on an 









) in e14 and e19 chicken embryos are presented in Table 5.2. For this 
calculation, blood and liver glucose enrichments were considered as precursors. Apparent 
glucose entry rate based on blood and liver enrichment was higher (P < 0.05) in e19 than in e14 
embryos, except for BW-adjusted glucose entry rate when blood glucose was the precursor pool 
where fluxes did not differ. Cori cycling and gluconeogenesis (non-Cori cycling) on an absolute 
basis were higher (P < 0.05) in e19 embryos for both precursor pools. When adjusted to a BW-
basis, liver Cori cycling as well as gluconeogenesis increased (P < 0.05) as the embryo 
developed. However, these two fluxes on a BW-adjusted basis were not different between e14 
and e19 embryos when blood was the precursor pool. 
In Exp. 2 when [U-
13
C] glycerol was infused, glycerol entry rate adjusted by BW tended 









) embryo, but statistical difference was not detected due to high variations within the 
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samples (Table 5.3). Although the fractional contribution of glycerol to gluconeogenesis was 
higher (P < 0.05) in e19 compared to e14 embryos when blood glucose was considered as the 
product pool, values were much lower than hypothesized. Overall, the contribution of glycerol to 
gluconeogenesis in e19 embryos averaged 2.1% when calculated using blood glucose as the 
product pool.  
Glucose and 3-Carbon Pool Contribution to Liver NEAA Synthesis 
The enrichments of [M+1], [M+2] and [M+3] of alanine, aspartate and glutamate in the 
liver free pool were markedly higher (P < 0.01) in e14 compared to e19 embryos when [U-
13
C] 
glucose was infused (Figure 5.3). As a result, the contribution of blood glucose to liver alanine, 
aspartate and glutamate synthesis was greater (P < 0.05) in e14 versus e19 embryos (Figure 5.4). 
Unfortunately, due to the limited volumes of blood that could be collected from e14 and e19 
embryos, the number of replicates was insufficient to perform statistical analysis on the 
contribution of the 3-carbon pool to liver [M+3] glutamate synthesis. Nonetheless, despite the 
limited number of observations (Figure 5.5), blood alanine and lactate contributions to [M+3] 
glutamate synthesis were numerically higher in e14 versus e19 embryos. By contrast, when liver 
alanine was considered as the 3-carbon precursor pool, [M+3] glutamate synthesis from alanine 
was numerically lower in e14 compared to e19 embryos.  
When [U-
13
C] glycerol was infused (Exp.2), the estimate of the contribution of blood 
glycerol to liver alanine and glutamate synthesis was greater (P < 0.05) in e19 embryos than in 
e14 embryos (Figure 5.6). Blood glycerol contribution to liver aspartate synthesis was not 
different due to high variation among samples. Compared to other 3-carbon substrates (10-50%), 
i.e., lactate and alanine in the blood, the contribution of glycerol (0.1-0.2%) to glutamate 






Figure 5.2 Speed adjustable syringe pump system. The pump was connected to a polyethylene 
tubing infusion line and fitted to a 0.5-mL syringe. A 27-gauge blunted needle was inserted into 
the chorio-allantoic compartment, secured to the egg shell with glue and connected to the 
polyethylene infusion line.  
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Synthesis of Acetyl-CoA from the 3-Carbon Pool          
When [U-
13
C] glucose was infused, the calculated enrichment of liver [M+2] acetyl-CoA 
was higher (P < 0.05) in e14 versus e19 embryos (Figure 5.7). The latter suggests that glucose 
contributed more, or that other substrates (e.g., fatty acids, leucine and lysine) contributed less to 
acetyl-CoA flux and, thus, Krebs cycle oxidation. Unfortunately, the limited number of replicates 
precluded statistical evaluation of the contribution of the 3-carbon pool to acetyl-CoA synthesis. 
Despite this limitation, the contribution of blood lactate to acetyl-CoA synthesis was numerically 
similar in e14 and e19 embryos (Figure 5.8). When blood alanine was considered as the 3-
carbon pool precursor, the contribution of alanine to acetyl-CoA synthesis was numerically 
higher in e19 compared to e14 embryos. 
In Exp. 2 when [U-
13
C] glycerol was infused, liver [M+2] acetyl-CoA enrichment was 
higher (P < 0.05) in e19 embryos than e14 embryos (Figure 5.7). The enrichment of [M+2] 
acetyl-CoA was similar in e19 embryos when comparing [U-
13
C] glucose and [U-
13
C] glycerol 
tracer infusions, although the enrichment in e14 embryos was lower when the eggs were infused 
with [U-
13
C] glucose. This may indicate the possible differences in the extent that glucose and 
glycerol are metabolized to acetyl-CoA in e14 embryos.  
PC and PDH Activity 
The activities of PC and PDH largely determine the anaplerotic flux of 3-carbon pool 
substrates into the Krebs cycle and into the acetyl-CoA pool for oxidation or fatty acid synthesis. 
Herein, the activity of PC in the liver was estimated by the ratio of [M+3] aspartate to [M+3] 
alanine. PC activity increased (P < 0.05) from e14 to e19 in embryos (Figure 5.9), suggesting 
increased anaplerosis in the liver of e19 embryos for gluconeogenesis, NEAA synthesis, or both. 
PDH activity was calculated from the ratio of [M+2] acetyl-CoA to [M+3] alanine, and this ratio 
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was higher in e14 compared to e19 embryos. The ratio of PC to PDH activity reflects the 
balancing of 3-carbon pool fluxes into the Krebs cycle for anaplerosis versus oxidation and fatty 
acid synthesis, and it was estimated by the ratio of [M+2] acetyl-CoA to [M+3] glutamate. 
(Figure 5.10). In e14 embryos, the ratio of PC to PDH activity was greater (P < 0.05) compared 
to e19 embryos. When [U-
13
C] glycerol was infused as the metabolic probe, liver PC activity in 
e14 embryos did not differ from that in e19 embryos. Moreover, the crude ratio of PC to PDH 




Table 5.1 Glucose 
13
C enrichment, and 
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Mass isotopomers (tracer:tracee ratio) 
 
13











 (%)  
 





Blood glucose  
e14 10.9 ± 3.3 15.3 ± 4.6 7.6 ± 2.5 36.3 ± 14.3 64.3 ± 19.6 282.1 ± 100.7 23.3 ± 4.0 48.6 ± 5.7 
e19 6.9 ± 3.3 9.1 ± 4.0 3.2 ± 1.6 16.7 ± 8.7 34.5 ± 15.7 134.8 ± 51.5 27.6 ± 12.8 53.6 ± 15.8 
age effect NS P < 0.05 P < 0.01 P < 0.05 P < 0.05 P < 0.01 NS NS 
Liver glucose  
e14 12.9 ± 4.3 18.3 ± 6.3 8.5 ± 3.3 14.9 ± 9.3 39.6 ± 13.7 54.5 ± 21.0 73.5 ± 7.0 73.6 ± 7.0 
e19 2.7 ± 1.1 3.7± 1.6 1.2 ± 0.6 2.1 ± 1.3 7.6 ± 3.21 9.7 ± 3.9 79.5 ± 5.6 79.5 ± 6.7 
age effect P < 0.001 P < 0.001 P < 0.001 P < 0.01 P < 0.001 P < 0.001 NS NS 
 
  1 
Values are moles of tracer/100 moles of tracee (means ± SD, n=6). 
 
2
               in Equation (4) 
 
3
               in Equation (3) 
 
4 
Calculated with Equation (2) 
  5 
Calculated with Equation (5) 




Table 5.2 Glucose entry rate, 
13
C and Cori cycling, and gluconeogenesis (GNG) based on blood and liver glucose enrichment in e14 






egg wt (g) 
Embryo 

























Blood glucose  
e14 60.8 ± 3.3 8.2 ± 0.5  0.23 ± 0.10 2.79 ± 1.10 0.11 ± 0.05 1.40 ± 0.60 0.11 ± 0.05 1.39 ± 0.53 
e19 59.9 ± 3.5 25.5 ± 2.4 0.80 ± 0.36 3.23 ± 1.54 0.47 ± 0.28 1.87 ± 1.10 0.33 ± 0.12 1.36 ± 0.63 
age effect  P < 0.0001 P < 0.01 NS P < 0.05 NS P < 0.01 NS 
Liver glucose  
e14   0.87 ± 0.44 10.66 ± 5.37 0.66 ± 0.35 8.06 ± 4.27 0.21 ± 0.10 2.59 ± 1.18 
e19   5.10 ± 1.48 19.67 ± 6.56 3.92 ± 1.22 15.09 ± 5.26 1.58 ± 0.76 4.58 ± 1.58 




Values are means ± SD (n=6). 
 
2
 Calculated with Equation (2). 
 
3
 Calculated with Equation (5) and multiplied with glucose entry rate. 
 4
 Calculated from the difference of glucose entry rate and Cori cycling. 





Table 5.3 Glycerol entry rate and contribution to gluconeogenesis (GNG) based on blood and liver glucose enrichment in e14 and e19 




         











Blood glucose  
e14 61.3 ± 2.2 7.3 ± 0.8 32.5 ± 24.9  452.9 ± 345.2 0.4 ± 0.4 
e19 63.4 ± 2.8 25.3 ± 1.6 28.1 ± 14.6 111.4 ± 57.9 2.1 ± 2.9 
age effect  P < 0.0001 NS NS P < 0.05 
Liver glucose  
e14     0.3± 0.3 
e19     1.3 ± 1.2 
age effect     NS 
 
1 
Values are means ± SD (n = 5). 
2
 Calculated with Equation (14). 
3
 Calculated with Equation (16). 










Figure 5.3 Enrichments of (a) blood glucose, (b) liver alanine, (c) liver aspartate and (d) liver 
glutamate isotopomers in e14 and e19 chicken embryos continuously infused (8 h) with [U-
13
C] 
glucose. Enrichments are expressed as moles of [
13
C] isotopomer per 100 moles of [
12
C] 

































Figure 5.4 Contribution (% of flux) of blood glucose to liver alanine (Ala), aspartate (Asp) and 
glutamate (Glu) synthesis in e14 and e19 embryos infused (8 h) with [U-
13
C] glucose. Values 
were calculated with Equations (6) and (7). Each bar represents the mean ± SEM (n = 6).*P < 


































Figure 5.5 Glutamate synthesis in the liver from the 3-carbon (3C) pool via activity of pyruvate 
carboxylase. Blood lactate and alanine, and liver alanine were considered as precursors in in 
Equation (8). Bars represent the mean ± SEM (n = 2-3 when blood lactate and alanine were 
considered and n = 2-6 when liver alanine was considered. Statistical comparisons of e14 vs e19 





































Figure 5.6 Contribution of blood glycerol to liver alanine (Ala), aspartate (Asp) and glutamate 
(Glu) synthesis in e14 and e19 embryos continuously infused (8 h) with [U-
13
C] glycerol.  
Values were calculated with Equations (17) and (18). Each bar represents the mean ± SEM (n = 





























C] glucose as the tracer [U-
13
























Figure 5.7 Liver [M+2] acetyl-CoA enrichment in e14 and e19 chicken embryos when infused 
with [U-
13
C] glucose and [U-
13
C] glycerol. [M+2] acetyl-CoA enrichment was calculated with 
Equation (11).  Values are expressed as moles [M+2] acetyl-CoA per 100 moles of 
12
C acetyl-
CoA. Bars represent the mean ± SEM (n = 6 when infused with [U-
13
C] glucose and n = 3-5 
when infused with [U-
13































Figure 5.8 Contribution of the 3-carbon (3C) pool to acetyl-CoA flux via activity of pyruvate 
dehydrogenase when [U-
13
C] glucose was infused. Values were calculated with Equation (13). 
Each bar represents the mean ± SEM (n = 2-3 for calculations with blood lactate or alanine as the 
3-carbon precursor pool and n = 6 for calculations with liver alanine as the 3-carbon precursor 
pool. Values on e19 when liver alanine was considered as 3-carbon precursor pool are not shown 
as these values exceeded 100%, which suggests that at e19 this pool is not theoretically sound.  


















































Figure 5.9 Pyruvate carboxylase (PC) and pyruvate dehydrogenase (PDH) activities in e14 and 
e19 chicken embryos when infused with [U-
13
C] glucose. PC activity was calculated with 
Equation (9), and PDH activity was calculated with Equation (10). Each bar represents the mean 



























































Figure 5.10 Crude relative activity of pyruvate carboxylase (PC) vs pyruvate dehydrogenase 
(PDH) in e14 and e19 chicken embryos when infused with [U-
13
C] glucose. The ratio was 














In the present study, a continuous infusion approach was employed for delivery of stable 
isotope tracers into the embryo for quantification of glucose and glycerol metabolism and 
general substrate utilization by e14 and e19 chicken embryos. [U-
13
C] Glucose and [U-
13
C] 
glycerol were chosen as metabolic probes to investigate developmental changes in 
gluconeogenesis and the contribution of 3-carbon pool substrates to the synthesis of NEAA. It 
was aimed to evaluate the two metabolic probes in studying Krebs cycle metabolism and related 
pathway activities. In this regard, this study was particularly interested in the comparative shifts 
in the fluxes of substrates through glycolysis and the Krebs cycle, and the activities of central 
enzymes (PC and PDH) as the embryo develops. It was expected that this evaluation would 
further reflect that as the embryo develops and grows, the metabolism of the macronutrients 
supplied from the yolk and albumen would shift from carbohydrate to fatty acid metabolism. 
The weights e19 chicken embryos differed remarkably from e14 embryos, featuring a 
two-fold increase in both experiments. Based on the  previous experiments (Chapters 3 and 4), 
we specifically selected the period between e14 and e19 because e14 is a critical developmental 
age when we observed enhancement of the energy-sensing mechanism of AMPK and embryo 
metabolism (e14 and e20) that also differed between small and large eggs and their different 
nutrient environments. The period between these two development ages represents the most 
dynamic period of embryo metabolism and hormonal changes (Wise and Frye, 1973; Scott et al., 
1981; Moran, 2007), and the most rapid rate of embryo growth. [U-
13
C] Glucose and [U-
13
C] 
glycerol were constantly delivered into the chorio-allantoic compartment of the eggs for three 
reasons. Firstly, it was technically challenging to insert a catheter into the vitelline or other 
vessels of the embryo without causing hemorrhage. Secondly, direct uptake of the infused tracers 
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into the blood circulation was possible because of the extensive capillary network surrounding 
the embryo at these stages. And, lastly, the tracers were infused at a constant, but very slow rate, 
during 8 h compared to the previous approach of daily bolus dosing of tracers in the laboratory. 
By the end of the constant infusion period, about 50 mg of tracer was delivered into the eggs and 
this is less likely to have caused a substrate response by the embryo compared to the single daily 
dosing approach. This amount was infused to ensure high rates of 
13
C incorporation into 
intermediates and products, and thus not only more accurate estimations of substrate fluxes but 
also greater distribution of 
13
C-skeletons in downstream pathways to allow for a more global 
assessment of pathway fluxes and enzyme activities. 
The two metabolic probes were delivered at a constant rate into the eggs and this has 
advantages. Firstly, the tracer was continuously delivered at a slow rate over an 8-h window to 
provide a better picture of the short-term changes in the developing embryos. Compared to daily 
injections of tracer for three to four consecutive days in the previous studies in the laboratory 
(Sunny and Bequette, 2010, 2011), the constant infusion protocol shortened the time course of 
the study. Secondly, frequent handling of the eggs was necessary when tracer was injected daily 
and this lends itself to greater possibility of damaging the structural integrity of the shell 
membranes and potentially disturbing embryo development. The latter approach often resulted in 
the death of the embryos before the tracer dosing period was complete.  Herein, the implantation 
of needle in the egg for constant tracer infusion was accomplished with only one puncture of the 
egg and eggshell membrane. Thirdly, the tracer was delivered continuously into the egg to attain 
a steady state enrichment and a high level of 
13
C incorporation into intermediates, after which the 
embryo was immediately sampled. With the daily bolus injection of tracer, it was unknown at the 
time of embryo sampling (3-5 h after dosing) whether tracer enrichment had remained steady. In 
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fact, in our previous work, large variations in substrate enrichments existed among embryos and 
resulted in elimination of data. And, lastly, the amount of tracer continuously infusion was 
administrated at a rate typically employed in humans and animals, Herein, the amount of tracer 
glucose infused represented about 18% of the blood glucose pool. 
When [U-
13
C] glucose was infused (Exp. 1), both blood and liver [M+3] and [M+6] 
glucose enrichments were lower in e19 embryos. This suggests an increased synthesis of glucose 
from other sources (i.e., unlabelled), which resulted in greater dilution of the [M+3] and [M+6] 
glucose enrichments. Higher glucose entry and greater Cori cycling and gluconeogenesis on both 
an absolute (blood and liver precursor pools) and body weight (liver precursor pool)-adjusted 
basis were observed in e19 compared to e14 embryos in Exp.1. This pattern of change in 
gluconeogenesis is consistent with known changes in corticosterone, an activator of 
gluconeogenesis.  In the study of Scott et al. (1981), corticosterone increased rapidly from e10-
e14 until e16, and remained at a higher level through to e18, with a tendancy to increase up to 
e20.  Further, the ratio of insulin to glucagon also increases during this period, which serves to 
promote the deposition of glucose into tissue glycogen (Lu et al., 2007). In consequence, higher 
gluconeogenesis in later developmental age leads to greater supply of glucose for glycogen 
accumulation in the liver and muscles. These observations are also in agreement with the earlier 
study (Chapter 3) where AMPK activity was highest on e14. Higher AMPK activity is expected 
to reduce the activity of energy consuming pathways, e.g., gluconeogenesis, while enhancing 
energy generating pathways. Moreover, the increased glucose entry rate on an absolute basis also 
suggested more glucose and glycogen synthesis as embryo weight increased. 
In Exp.2, when eggs were infused with [U-
13
C] glycerol, a higher contribution of glycerol 





glycerol in glucose has been used to estimate the contribution of glycerol to gluconeogenesis 
(Kalhan and Parimi, 2000). However, current estimates of the contribution of glycerol to glucose 
synthesis are variable. Studies in healthy term infants during the first 48 h after birth found that 
the contribution of glycerol accounted for 10-20% of glucose synthesized (Bougneres et al., 
1982; Pater et al., 1992; Sunehag et al., 1996a). In extremely preterm infants on the first day after 
birth, gluconeogenesis from glycerol was much lower and ranged from 1.7-37.6%, with a median 
value of 5% (Sunehag et al., 1996b). The e19 chicken embryo might be considered to be at a 
similar physiological state as the preterm infant. In this respect, the finding in the e19 chicken 
embryo that glycerol contributes only 2.1% (1.3-6.0%) to gluconeogenesis would appear to be 
consistent with that of the preterm infant. In addition, these results further demonstrate that other 
substrates, such as amino acids and lactate, make a more substantial contribution to 
gluconeogenesis at this stage of embryo development. 
In young and adult animals, glucose is an important contributor to NEAA synthesis 
(Pascual et al., 1998).  Metabolism of glucose leads to significant distribution of its carbon 
skeletons throughout the glycolytic pathway and in the Krebs cycle where carbon skeletons are 
used for NEAA synthesis. In the estimate of blood glucose to liver NEAA synthesis in Exp.1, the 
contribution of glucose to alanine, aspartate and glutamate synthesis decreased as the embryo 
developed. Although the proportional contribution of glucose to NEAA synthesis was 
comparable to another study (Sunny and Bequette, 2010), this observation is not consistent with 
the original hypothesis that NEAA synthesis would be promoted as the embryo grows. The 
possible explanation is that by e14, the embryo is structurally completed (Moran, 2007). The 
embryos require a large amount of amino acids for tissue protein gain whereas by e19, embryo 
protein mass reaches the maximum.  More NEAA for protein synthesis would be demanded for 
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the rapid growth of e14 embryos. The contribution of blood glucose to NEAA synthesis was 
higher in e14 embryos demonstrated that glucose was spared for glycogen accumulation in e19 
embryos. In fact, the isotopic profiles of [M+1], [M+2], and [M+3] liver alanine, aspartate and 
glutamate also showed a higher incorporation of glucose carbon by e14 embryos. 
The synthesis of glutamate from 3-carbon substrates (i.e., lactate and pyruvate) arises 
from oxaloacetate. Thus, pyruvate is converted to oxaloacetate via PC for entry into the Krebs 
cycle. The contribution of blood lactate and alanine to the synthesis of [M+3] glutamate was 
found to be higher in e14 than e19 embryos, whereas the ratio was lower in e14 embryos when 
considering liver alanine as the 3-carbon pool (Exp. 1). Although this needs to be further 
confirmed due to limited replicates, it certainly provides preliminary information on the 
contribution of 3-carbon substrates to the synthesis of NEAA.  
In Exp. 2 when [U-
13
C] glycerol was the tracer, the proportions of alanine, aspartate and 
glutamate derived from the 3-carbon pool was relatively smaller compared to Exp.1, where the 
contribution of other 3-carbon sources to NEAA production was estimated. The contribution of 
glycerol to alanine, aspartate and glutamate synthesis was higher in e19 versus e14 embryos. A 
higher contribution of glycerol to glucose synthesis was also observed in e19 embryos. One 
explanation is that on e14, when there is a large demand for energy for embryo development, 
glycerol that is liberated from yolk triglycerides is metabolized in the Krebs cycle to produce 
energy. 
The synthesis of [M+2] glutamate arises primarily via decarboxylation of [M+3] 
substrates (pyruvate) by action of PDH to form [M+2] acetyl-CoA. While [M+3] glutamate can 
only be derived from [M+3] pyruvate via PC, the ratio of [M+3] glutamate and [M+2] acetyl-
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CoA gives a direct measure of PC versus PDH activity. The ratio of PC to PDH activity was 
higher in e14 embryos regardless of whether the estimation employed glucose or glycerol as the 
tracer. Relatively lower activity of PDH in e14 embryos indicated less production of acetyl-CoA 
from 3-carbon substrates. Therefore, the acetyl-CoA pool must derive from other sources, such 
as via fatty acid β-oxidation. The latter conclusion is consistent with calorimetric measurements 
of developing chicken embryos. Hamidu et al. (2007) measured respiratory quotient (RQ) of 
developing eggs and observed the RQ to be lower for e14 compared to e19 embryos. A low RQ 
(e.g., 0.7) represents a high level of fatty acid oxidation compared to a high RQ (e.g., 1.0) where 
carbohydrates are predominately oxidized, as the former requires a greater O2 supply. 
In summary, higher glucose entry rate, Cori cycling, and gluconeogenesis were observed 
in e19 compared to e14 embryos. The contribution of glucose to NEAA synthesis was higher in 
e14 than in e19 embryos. These metabolic shifts are consistent with the rapid development of the 
embryo at e14 and the high demands for glycogen accumulation in e19 embryos. The higher rate 
of lipolysis (glycerol turnover) and contribution of glycerol to both gluconeogenesis and NEAA 
synthesis in e19 embryos indicates that glycerol is an important anaplerotic substrate in the 





C] glycerol, provided rich information about the developmental adaptations in 
gluconeogenesis, the Krebs cycle and activities of related pathways.  Results based on [U-
13
C] 
glucose infusion highlighted the importance of glucose carbon recycling and the utilization of 
several substrates that contribute to the 3-carbon precursor pool for synthesis of NEAA and 
acetyl-CoA. The results based on the [U-
13
C] glycerol tracer provide strong evidence of the 
changing role of lipolysis in provision of fatty acids for energy, and the utilization of triglyceride 
glycerol for gluconeogenesis and NEAA synthesis. The constant tracer infusion approach 
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developed in this study is also valuable for investigating other aspects of embryo metabolism and 
pathway activities. For example, glycine, serine and threonine metabolism that differed in the 
liver metabolism in eggs from young versus old hens using [U-
13

















Summary and Conclusions 
 
This thesis research aimed to determine the influences of egg size and hen age on embryo 
development, and whether metabolic events are altered accordingly to allow for adaptations at 
different developmental ages and nutrient environments. Three experiments were conducted with 
the objective to investigate embryo metabolism and substrate partition in response to nutrient 
(egg yolk and albumen) availability and physiological stage. Western blot and ELISA were used 
to determine AMPK activity, and metabolomic profiling was applied to compare embryo 
metabolism in eggs of two sizes and from different ages of hens. A constant stable isotope 
infusion approach was employed for delivery of [U-
13
C] glucose and [U-
13
C] glycerol into the 
chorio-allantoic fluid of e14 and e19 embryos to quantify gluconeogenesis and substrate partition 
and utilization in the Krebs cycle and related pathways. 
The results demonstrated that activity of the energy-sensor, AMPK, was higher in large 
compared to small eggs, and activity peaked on e14 in both size eggs. This suggests greater 
energy demand in embryos from large eggs to support their more rapid growth during later term 
development. Liver metabolism differed in e14 and e20 embryos from 32 wk compared to 51wk-
old hens, but was not found to be different in embryos from small versus large eggs. The residual 
yolk contained a higher proportion of oleic acid and linolenic acid in eggs from older hens. This 
suggests that hen age influences the deposition of fatty acids into the yolk which subsequently 
affects embryo development and nutrient utilization. Moreover, embryo metabolism underwent 
dramatic changes as the embryo developed and displayed an interesting pattern with respect to 
different developmental ages. For example, metabolism was distinctly different between 
posthatch day 1hatchlings and embryos on e14, e17 and e20. This observation supported our 
hypothesis that embryo metabolism adapts to different egg nutrient compositions (yolk and 
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albumen) and physiological stages that enables normal and maximum embryo growth in ovo. In 
consequence, chicks would be prepared metabolically to face different nutrient environments at 
hatch. 
During later development, the ability of the embryo to utilize substrates derived from 3-
carbon sources or from amino acids to synthesize glucose increased as the embryo developed. 
This is consistent with the observations that gluconeogenesis increased from e14 to e19. These 
observations are also consistent with other studies that glucose synthesis is promoted for 
glycogen storage close to the time of hatching. Mass isotopomer distribution patterns of NEAA 
in liver indicated that glucose carbon made a larger contribution to NEAA synthesis in e14 
compared to e19 embryos. At this critical developmental age, the embryo is structurally 
complete but requires a significant supply of amino acids for tissue protein expansion. Glycerol’s 
contribution to glucose synthesis was only 5%, and the contribution of glycerol to glutamate 
synthesis was relatively small compared to other 3-carbon substrates, e.g. lactate, alanine. The 
comparative activities of pyruvate carboxykinase (PC) and pyruvate dehydrogenase (PDH) in the 
liver determine the partition of 3-carbon substrates to produce either oxaloacetate or acetyl-CoA, 
respectively. Our observation that the ratio of PC to PDH was higher in e14 than in e19 embryos 
suggests that a greater proportion of acetyl-CoA flux in the e14 embryo liver derives from fatty 
acid metabolism rather than from 3-carbon substrates. 
Although previous studies have assessed the effects of egg size or maternal age on 
embryo development and hatchability, the two factors were often confounding. It was not clear 
from these studies the actual influence of egg size, and hen age per se on embryo metabolism 
and development. Hence, the experiments in this thesis were specifically designed to study the 
separate effects of egg size and hen age on embryo metabolism and growth.  To our knowledge, 
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quantitative information on embryo metabolism still remains limited, especially the lack of data 
on the metabolic adaptations of the developing embryo. In addition, there is a lack of information 
on substrate utilization by developing chicken embryos when egg nutrient composition is 
different, i.e. higher yolk to albumen ratio in eggs from old hens. The results from this thesis 
allow for a better understanding of which of the two, hen age or egg size, has a greater influence 
on embryo development. Knowledge of nutrient partition and utilization in developing chicken 
embryos will provide a better view of how and whether the embryos adapts to changing nutrient 
environments and physiological states. The metabolomic profiling and in ovo constant stable 
isotope infusion approaches employed in this thesis could also be applied using alternative 
metabolic probes to better understand embryo metabolism in vivo. For example, [U-
13
C] 
threonine can be used to study glycine, serine and threonine metabolism. This metabolic pathway 
is known to be central in support of embryonic stem cell proliferation, and glycine metabolism is 









Appendix a, b 
a.                                                                                                          b. 
 
a. Principal component analysis (PCA) of e17 metabolomic profile (Exp. 1). The first three characters represent the embryo 
developmental age (e17) followed by age (32 wk-, 51 wk-) and replicates (1-5 samples). b. PCA of posthatch day 1 metabolomic 
profile (Exp. 1). The first three characters represent the embryo developmental age (P1) followed by age (32 wk-, 51 wk-) and 
replicates (1-5 samples). PCA score plot cannot distinguish the metabolic profiles of liver metabolites in eggs from 32 wk (Δ) vs 51 
wk (+) old hens on e17 and posthatch day 1.  
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Appendix c, d 
            c.                                                                                                           d. 
 
c. Principal component analysis (PCA) of e14 liver metabolomic profile (Exp. 2). The first three characters represent the embryo 
developmental age (e14) followed by age (45 wk-) and size and replicates (small, large, 1-5 samples). d. PCA of e17 liver 
metabolomic profile (Exp. 2). The first three characters represent the embryo developmental age (e17) followed by age (45 wk-) and 
size and replicates (small, large, 1-5 samples). PCA score plot cannot distinguish the metabolic profiles of liver metabolites in eggs of 
small (+) vs large (Δ) on e14 and e17.  
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Appendix e, f 
            e.                                                                                                           f.  
 
e. Principal component analysis (PCA) of e20 liver metabolomic profile (Exp. 2). The first three characters represent the embryo 
developmental age (e20) followed by age (45 wk) and size and replicates (small, large, 1-5 samples). f. PCA of posthatch day 1 liver 
metabolomic profile (Exp. 2). The first three characters represent the embryo developmental age (e17) followed by age (45 wk) and 
size and replicates (small, large, 1-5 samples). PCA score plot cannot distinguish the metabolic profiles of liver metabolites in eggs of 
small (+) vs large (Δ) on e20 and posthatch day 1.  
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Appendix g, h 
           g.                                                                                                             h.  
 
g. Principal component analysis (PCA) of e17 blood metabolomic profile (Exp. 1). The first three characters represent the embryo 
developmental age (e17) followed by age (51 wk, 32 wk) and replicates (1-5 samples). h. PCA of e20 blood metabolomic profile 
(Exp. 1). The first three characters represent the embryo developmental age (e20) followed by age (51 wk, 32 wk) and replicates (1-5 
samples). PCA score plot cannot distinguish the metabolic profiles of liver metabolites in eggs from 32 wk (Δ) vs 51 wk (+) on e17 






i. Principal component analysis (PCA) of posthatch day 1 blood metabolomic profile (Exp. 1). The first three characters represent the 
embryo developmental age (P1) followed by age (51 wk, 32 wk) and replicates (1-5 samples). PCA score plot cannot distinguish the 




Appendix j, k 
             j.                                                                                                          k.  
 
j. Principal component analysis (PCA) of e14 blood metabolomic profile (Exp. 2). The first three characters represent the embryo 
developmental age (e14) followed by size (small, large) and replicates (1-5 samples). k. PCA of e17 blood metabolomic profile (Exp. 
2). The first three characters represent the embryo developmental age (e17) followed by size (small, large) and replicates (1-5 




Appendix l, m 
            l.                                                                                                            m. 
 
l. Principal component analysis (PCA) of e20 blood metabolomic profile (Exp. 2). The first three characters represent the embryo 
developmental age (e20) followed by size (small, large) and replicates (1-5 samples). m. PCA of posthatch day 1 blood metabolomic 
profile (Exp. 2). The first three characters represent the embryo developmental age (P1) followed by size (small, large) and replicates 
(1-5 samples). PCA score plot cannot distinguish the metabolic profiles of blood metabolites in eggs of small (+) vs large (Δ) on e20 
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